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ABSTRACT
Most human inherited diseases and cancers are known to be caused by mutations in
nuclear genes. But the primary causes of many of these mutations are still unknown.
Determination of mutational spectra in disease-related genes in nontumorous tissues may
provide direct evidence as to whether a specific mutagenic agent or pathway is involved in a
particular human cancer. Such a study, however, requires the detection of a few mutant
alleles from a vast excess of wild-type sequences in the presence of large quantities of
cellular DNA.
In this research, a means has been developed to detect point mutational spectra in
100-bp single-copy nuclear sequences at mutant fractions equal to or greater than 10-6. The
approach is independent of phenotypic selection and can thus be used to scan for point
mutations in tissues and organs. The desired sequences are enriched 10 4-fold from the
genomic DNA by sequence-specific hybridization coupled with an improved biotin-
streptavidin capture system. The rare mutant sequences are enriched 100-fold relative to
wild-type sequences by wide-bore constant denaturant capillary electrophoresis (CDCE).
The mutant-enriched sample is then amplified using a high-fidelity DNA polymerase
without obscuring mutant signals by PCR noise. Amplified mutant sequences are further
enriched via two rounds of CDCE coupled with high-fidelity PCR. The desired mutants
which are represented as distinct peaks on an electropherogram are then isolated and
sequenced.
This approach has been tested by measuring N-methyl-N'-nitro-N-nitrosoguanidine
(MNNG) induced point mutations in a 121-bp sequence of the adenomatous polyposis coli
(APC) gene cDNA bp 8543-8663 in human lymphoblastoid MTl cells. Twelve MNNG-
induced mutations were reproducibly observed in MNNG-treated cells at fractions between
2 x 10-6 and 9 x 10-6. All twelve mutations were GC -> AT transitions, eleven of which
occurred at guanine residues preceded (5') by a purine. Limit to the sensitivity of this
approach arises from mutants created by PCR, which are represented by fourteen GC ->
TA transversions observed in untreated cells at fractions around 10-6. The approach
described herein is general for all DNA sequences suitable for CDCE analysis; such
suitable sequences are found in nearly all prokaryotic and eukaryotic genes.
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1. INTRODUCTION
Seymour Benzer and Ernst Freese (1958) demonstrated that mutagens induce
unique distributions of point mutations with regard to kind and position and called these
distributions (point) mutational spectra. Since then, mutational spectrometry has become a
powerful tool to study mutational mechanisms in prokaryotic and eukaryotic cells (Fuchs et
al., 1981; Miller, 1983; Thilly, 1990). However, in all of these studies rare mutant cells
were recognized and isolated on the basis of an altered phenotype which conferred them the
ability to grow under selective conditions. Such methods preclude the analysis of genes for
which no selective conditions have been devised in single cell systems. They also preclude
the analysis of any gene in human tissues the cells of which cannot yet be grown in vitro.
To overcome these limitations to mutational spectrometry, our laboratory has been
developing means to "select" mutants based on differences in the cooperative melting
behavior between wild-type and mutant DNA sequences. These efforts are built upon the
original demonstration by Fischer and Lerman (1983) that small differences in DNA
melting temperatures create clear and discernible differences in the electrophoretic mobility
of DNA upon passing through a gel matrix under partially denaturing conditions. Their
technique has been extended to constant denaturant capillary electrophoresis (CDCE) which
uses laser-induced fluorescence detection and replaceable linear polyacrylamide matrices
(Khrapko et al., 1994). In comparison to slab gel electrophoresis, CDCE offers superior
performance with high resolution, high sensitivity, fast separation and easy recovery of
desired DNA species (Khrapko et al., 1994).
A mutational spectrometry approach has recently been developed in our laboratory
in which mutant sequences are first separated from wild-type DNA by constant denaturant
gel electrophoresis (CDGE), amplified by high-fidelity polymerase chain reaction (PCR),
and further enriched and separated by CDCE (Khrapko et al., 1997a). This approach has
enabled us to scan for point mutations in a 100-base pair (bp) mitochondrial DNA sequence
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in human cells and tissues. Reproducible mitochondrial point mutational hotspots were
discovered at frequencies from 10-5 to greater than 10-4 (Khrapko et al., 1997b; Coller et
al., 1998; Marcelino et al., 1998).
The goal of this thesis project is to extend the CDCE/high-fidelity PCR approach to
the detection and measurement of mutational spectra in single-copy nuclear genes in human
cells and tissues. Application of this approach to nuclear genes was not straightforward.
Both the cellular copy numbers and the point mutant fractions of nuclear genes are several
hundred-fold lower than those of the mitochondrial DNA (Robin and Wong, 1988; Grist et
al., 1992; Robinson et al., 1994; Khrapko et al., 1997a; Khrapko et al., 1997b). In
practical terms this means sorting through about 150 picograms of total cellular DNA to
find a typical mitochondrial hotspot but 3 micrograms to find a typical nuclear hotspot.
Unfortunately, the exquisite separation capability of capillary electrophoresis (CE) was
hampered by a limited loading capacity of DNA (less than 100 nanograms) (Ruiz-Martinez
et al., 1993). It was clear that one had to achieve a significant enrichment of the desired
nuclear sequences prior to CE separation and/or increase the loading capacity of CE.
The criterion for an assay of sufficient sensitivity to detect nuclear hotspots differs
among tissues. Studies in peripheral T-lymphocytes have shown that the average mutant
fraction in the nuclear hprt and HLA loci is about 10-8 per bp in middle aged humans (Grist
et al., 1992; Robinson et al., 1994). To obtain reproducible observations of nuclear
hotspots in blood requires one to work with 109 nucleated cells at a sensitivity of 10-7
(Leong et al., 1985). Fortunately, in assaying for mutations in most organs, anatomically
distinct sectors may be excised and analyzed in series (Coller at al., 1998). Mutations in a
stem cell which are of primary interest to us may be found as a colony after the mutations
are transmitted to the transitional and terminal cells of that stem cell's turnover unit. Thus a
sample consisting of 5 x 107 cells with 108 alleles and a turnover unit size of 128 would
have a mutant fraction of 10-6 if one stem cell mutated at some previous time. Our
experience with dissecting human lungs and colons for mitochondrial mutation studies
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suggested that a sample size as large as 0.5 g or 108 cells for parenchymal epithelia is a
practical upper limit for us to set the goal to achieve a detection sensitivity of 10-6.
Two crucial technical developments were made in this project that extended the
CDCE/high-fidelity PCR approach to mutational spectrometry of nuclear genes. The first
development was a protocol involving sequence-specific hybridization coupled with a
biotin-streptavidin capture system to isolate the desired sequences from bulk genomic
DNA. The second development was a two-step CE separation procedure using a wide-
bore capillary to highly enrich the mutant sequences in the presence of residual cellular
DNA prior to high-fidelity PCR.
As an initial sequence for developmental work, a 271 -bp fragment of the human
adenomatous polyposis coli (APC) gene (APC cDNA bp 8434-8704) (Groden et al., 1991)
was used. The chosen APC fragment has the necessary contiguous high and low
isomelting domains for separation of mutants from wild-type (Fischer and Lerman, 1983)
as well as conveniently located restriction sites. The target sequence in which mutations
can be detected comprises 121 basepairs (APC cDNA bp 8543-8663) within the low
melting domain. It is located in the untranslated portion of the APC gene exon 15 where
mutations have not been found associated with colon cancer. This, paradoxically, is a
valuable quality for the study of mutagenesis in somatic tissues which requires the use of
sequences in which mutations have no in vivo phenotypic advantage or disadvantage. The
sensitivity and reproducibility of the improved CDCE/high-fidelity approach was
demonstrated in measuring the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced
point mutations in the APC target sequence in nearly diploid human lymphoblastoid MT 1
cells.
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2. LITERATURE REVIEW
2.1. Genetic changes in humans
This section reviews the nuclear gene mutations that have been detected in humans
in vivo, including germline mutations associated with inherited diseases, somatic mutations
associated with tumors and somatic mutations in healthy humans. The discussion is
focused on point mutations since they provide the most detailed information about the
specificity and mechanisms involved in mutagenesis.
2.1.1. Germline mutations associated with inherited diseases
Mutations occurring in germinal cells are the causes of many inherited diseases in
humans. To date, nearly 12,000 different germline mutations in a total of 636 nuclear
genes have been reported in the literature and collected by The Human Gene Mutation
Database (HGMD) (Cooper et al., 1998). Each mutation recorded in the HGMD has been
logged only once in order to avoid confusion between recurrent and identical-by-descent
lesions. As shown in Table 1, the vast majority of mutations associated with inherited
diseases are single base-pair substitutions (70.5%) and deletions (21.6%). The remainder
consists of insertions and duplications (6.5%), indels (0.7%), repeat expansions (0.1%)
and complex rearrangements not covered by the above categories (0.6%). Among the
single base-pair substitutions, 7271 different mutations have been found in the coding
regions of 547 different genes (Krawczak et al., 1998). The number and type of these
substitutions are shown in Table 2. It can be seen that there is a hierarchy of nucleotides
with respect to their propensity to undergo substitution, that is, G > C > T > A. There is
also a highly significant excess of transitions (62.5%) over transversions (37.5%). The
excess of transitions observed is partially attributed to those at CpG dinucleotides (i.e.,
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Table 1. Number and type of germline mutations associated with human inherited diseases.
Mutation type Number % of Total
Single base-pair substitutions 8436 70.5
Small deletion ( 20 bp) 1857 15.5
Small insertion ( 20 bp) 653 5.5
Small indels ( 20 bp) 82 0.7
Repeat expansions 15 0.1
Gross deletion (> 20 bp) 736 6.1
Gross insertions and duplications (> 20 bp) 122 1.0
Complex rearrangements including inversions 71 0.6
Total 11972 100.0
(Adapted from Cooper et al., 1998)
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Table 2. Number and type of germline single base-pair substitutions
in gene coding regions.
No. of substitutions by nucleotide
Original
nucleotide T C A G Total
T ... 654 271 312 1237
C 1632 (940)a ... 371 340 2343
A 201 163 ... 538 902
G 619 453 1717 (7 3 5 )b ... 2789
Total 2452 1270 2359 1190 7271
transitions.
transitions.
(Adapted from Krawczak et al., 1998)
(a) Number in parentheses is the number of CpG -> TpG
(b) Number in parentheses is the number of CpG -> CpA
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CpG -> TpG/CpA mutations), which account for 23% of all substitutions and for 36.9% of
all transitions. It should be noted that considerable variation exists in the relative
proportions of the different types of mutation found for different gene loci, which probably
reflects both the gene structure and the selective pressure to generate a disease phenotype
(Cooper and Krawczak, 1993; Mohrenweiser, 1994).
The observed preponderance of C -> T and G -> A transitions at CpG dinucleotides
in human germline mutations is believed to be due to the high propensity of 5-
methylcytosine (5-meC) to undergo spontaneous deamination to thymine (Duncan and
Miller, 1980; Cooper and Youssoufian, 1988). In humans, 70 - 90% of 5-meCs occur in
CpG dinucleotides (Cooper, 1983), rendering the CpG dinucleotide a mutational hotspot.
To disentangle the effects that mutation and selection have on the observed germline
mutation, Cooper and Krawczak (1993) have devised an iterative multivariate procedure to
translate the observed proportions into relative single base-pair substitution rates which are
corrected for the two confounding effects of differential codon usage and clinical
observation likelihood. The relative mutation rate for either CpG -> TpG or CpG -> CpA
has been estimated to be five times higher than the average base substitution rate (Krawczak
et al., 1998). Among all of the mutated CpG dinucleotides, there are significant differences
in the relative mutation rate depending on the flanking nucleotides (Krawczak et al., 1998).
A preference for 5' pyrimidines and 3' purines has been observed among the mutated
dinucleotides (Krawczak et al., 1998). This could be due to the sequence-dependent
efficiency of both DNA methyltransferase action and G:T mismatch repair (Bolden et al.,
1985; Sibghat-Ullah and Day, 1993). Some studies have reported a strand bias in either
the CpG deamination frequency or the efficiency of G:T mismatch repair, with CpG ->
TpG transitions outnumbering CpG -> CpA transitions (Skandalis et al., 1994; Leader et
al., 1995). This also seems to be true for the collection of germline single base-pair
substitutions (Table 2). However, after taking into account the observational bias due to
codon usage and magnitude of amino acid exchange, the relative mutation rate of CpG ->
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CpA is estimated to be 1.4-fold higher than that of CpG -> TpG (Krawczak et al., 1998).
5-meC is known to occur at low frequency in non-CpG dinucleotides within triplets
of the form CpNpG (Woodcock et al., 1998). However, the relative mutation rates of
CpNpG -> TpNpG (N # G) and CpNpG -> CpNpA (N # C) transition in the HGMD
database are found to be not significantly higher than the average substitution rate
(Krawczak et al., 1998).
In addition to the hypermutability of CpG dinucleotides, some subtle and very
localized effects of the surrounding DNA sequence on the relative single base-pair
substitution rates have been observed in the germline mutation database (Krawczak et al.,
1998). A substantial proportion of substitutions take on the identity of one of the bases
immediately flanking the mutated site. This mutational bias toward next neighbors is
potentially explicable in terms of misalignment mutagenesis involving highly localized
DNA slippage, misincorporation and realignment events at the replication fork, between
template and primer (Kunkel, 1992). A moderate correlation between the thermodynamic
stability of DNA triplets and the relative mutability of the central nucleotide of a triplet has
also been observed. This suggests either inefficient DNA replication in regions of high
stability or transient stabilization of misaligned intermediates (Krawczak et al., 1998).
Several other endogenous mutagenic mechanisms have been proposed to explain
the remaining 77% germline single base-pair substitutions that are not explicable by
methylation-mediated deamination. These include DNA polymerase replication errors,
depurination of DNA and DNA damage by oxygen free radicals (Loeb and Cheng, 1990).
In mammalian cells, three classes of DNA polymerases, a, P and 6, are responsible for the
replication and repair of nuclear DNA. The error rate and mutational specificity of each
polymerase have been determined in vitro (Kunkel, 1985; Thomas et al., 1991; Kunkel,
1992). It has been shown that the most frequent types of errors produced by these DNA
polymerases are single base-pair substitutions, followed by minus-one-base frameshifts.
With respect to single base-pair substitutions, transitions are more frequent than
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transversions. When the observed frequencies and types of human germline single base-
pair substitutions were compared with the rates and types of errors produced by the DNA
polymerases c, P and 8 in vitro, a significant correlation was found between the observed
substitutions in humans and those from polymerase f (Cooper and Krawczak, 1993). This
observation supports the postulate that a substantial proportion of the single base-pair
substitutions underlying human inherited diseases are caused by misincorporation during
DNA replication.
Depurination of DNA results from cleavage of the N-glycosylic bond which is the
most frequent spontaneous alteration in the chemical structure of DNA under physiological
conditions (Lindahl and Nyberg, 1972). Because most DNA polymerases tend to insert
deoxyadenosine opposite the non-instructional apurinic site (Kunkel, 1984; Loeb and
Preston, 1986; Hevroni and Livneh, 1988), these lesions could give rise to a high
frequency of transversion if they remain unrepaired prior to DNA replication. Transversion
has also been observed as the predominant type of base substitution caused by oxidative
damage to DNA, presumably from 8-hydroxoguanine (Cheng et al., 1992; Retel et al.,
1993). However, since transversions are under-represented in the database of single base-
pair substitutions associated with human inherited diseases, it is concluded that neither
depurination nor endogenous oxidative damage is a major mechanism for spontaneous
mutation in humans (Cooper and Krawczak, 1993).
In humans, despite numerous studies of the potential genetic consequences of
exposure to known in vitro mutagens, there has not been a single mutagenic agent being
identified as the cause of a genetic disorder (Cooper and Krawczak, 1993). The analysis of
the human germline mutation database has shown that the majority of the germline
mutations are likely resulted from endogenous mutagenic processes involving chemical
degradation, error-prone DNA replication and repair, and possibly, damage by endogenous
mutagens. These also include a large proportion of small deletions and insertions in the
database which appear to occur as a consequence of replication slippage mediated by the
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presence of direct or inverted (palindromic) repeats in the immediate vicinity (Cooper and
Krawczak, 1993).
The germline mutation data logged in the HGMD does not allow for a direct
estimation of the mutation rates in absolute terms. This is due to a lack of information on
the actual numbers of recurrent mutations and the numbers of total meioses screened for
their occurrence. In addition, for a mutation to be found associated with disease, it must
cause a phenotype sufficiently severe that it comes to clinical attention, yet must not cause
embryo lethality. This implies that clinically observed mutations only represent a subset of
all mutational events actually occurring in a population.
Several studies have attempted to estimate the germline mutation rates in a small
number of gene loci (reviewed by Mohrenweiser, 1994 and Simpson, 1997). Depending
on the approach and loci investigated in each study, the average germline mutation rates
have been estimated to be between 0.2 x 10-5 and 2 x 10-5 per loci per generation. The
nucleotide substitution rate has been estimated to be between 2 x 10-9 and 1 x 10-8 per
generation. Although different loci may have different inherent mutation rates, depending
on the size and sequence of the gene being screened, the difference in the estimated
mutation rates may also reflect differences in the frequency of different molecular events
among loci and the analytical strategies employed to detect them. All of the estimates are
limited by the small number of events identified in any one screening effort. For these
reasons, the estimated germline mutation rate may deviate significantly from the actual
mutation rate.
2.1.2. Somatic mutations associated with tumors: the p53 and APC gene
The p53 gene
The p53 tumor suppressor gene is localized on chromosome 17p 13.1 and
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comprises 11 exons. It encodes a nuclear phosphoprotein of 393 amino acids with
transcriptional transactivation activity ((Levine et al., 1991). p5 3 participates in many
cellular functions including cell cycle control, DNA repair, apoptosis, genomic plasticity
and differentiation (Vogelstein and Kinzler, 1992; Greenblatt et al., 1994). Mutations in the
p53 gene have been found in about half of all somatic cancer types. Germline p53 mutation
is the cause of Li-Fraumeni syndrome, a rare familial autosomal dominant cancer syndrome
characterized by early-onset sarcomas, brain tumors, premenopausal breast cancer,
leukemias and adrenocortical tumors (Malkin et al., 1990).
A comprehensive p53 mutation database has been developed at the International
Agency of Research on Cancer (IARC). To date, this database contains more than 9000
entries of p53 somatic mutations and 100 entries of p53 germline mutations in human
tumors (Hainaut et al., 1998). p53 has a large mutational target size. More than 280 out of
the 393 codons are found mutated in tumors, with about 74% of all of these mutations
being missense mutations. In this respect, p53 differs from other tumor suppressor genes
(such as APC, BRCA-1, p16 and RB) which are frequently inactivated by frameshift or
nonsense mutations, and the ras oncogenes which are activated by mutations at three well-
defined codons (Hussain and Harris, 1998). One explanation for the high prevalence of
p53 mutation in cancer is that the missense mutations can cause both a loss of tumor
suppressor function and a gain of a transdominant oncogenic activity (Harris, 1996).
The distribution of the tumor-associated p53 point mutations in the coding region of
the gene is not random (Fig. 1). About 75% of all missense mutations cluster in exons 5-8
(codons 126-306), which is the sequence-specific DNA binding region of the protein and
highly conserved through evolution (Soussi et al., 1990). Five out of the six dominant
mutational hotspots (codons 175, 245, 248, 273 and 282) observed in the somatic
spectrum are also hospots observed in the germline spectrum (Fig. 1). All five hotspots are
at methylated CpG dinucleotides. CpG -> TpG/CpA transition is the major type of
mutation found at these sites in both somatic and germline spectra, suggesting that
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Figure 1. Distribution of the somatic and germline point mutations in the p53 gene in
human tumors.
The horizontal axis represents the p53 codon sequence. The size of vertical bars represents
the number of mutations found at a particular codon. Hotspot codon numbers are indicated.
Data were obtained from the IARC p53 database (Hainaut et al., 1998).
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endogenous deamination of 5-meC is the major mechanism responsible. It has been
demonstrated that upon exclusion of a small proportion (12%) of tissue- and site-specific
point mutations, the spectrum of somatic mutations of the p53 gene closely resembles that
of the overall germline mutations of other genes (Krawczak et al., 1995). This similarity
has promoted the hypothesis that the majority of p53 somatic mutations are of endogenous
origin and selected for during the process of cellular transformation (Krawczak et al.,
1995).
Nevertheless, it has been recognized that the p53 mutation patterns in tumors are
tissue-specific which may provide clues to the etiology of human cancer (Hollstein et al.,
1991; Greenblatt et al., 1994; Hussain and Harris, 1998). Fig. 2 compares the p53
mutation patterns in somatic tumors of colon, liver, skin and lung. The p53 mutations in
colon cancer are characterized by a high proportion (50%) of CpG -> TpG/CpA transitions
at CpG sites. Most of the transitions occur at the five hotspot positions which are the same
as those in the germline spectrum (Fig. 1 and 2). The similarity between the p53 mutation
pattern of somatic colon cancer and that of Li-Fraumeni syndrome indicates that, like
germline mutations, the p53 mutations in colon cancer are primarily caused by endogenous
deamination of 5-meC. The p53 coding region contains 39 CpG dinucleotides (23 in exons
5-8), all of which are methylated in all human tissues and cell types analyzed (Tornaletti
and Pfeifer, 1995). The nonrandom distribution of the transitions among these CpG sites
may reflect selection bias for particular amino acids or the sequence-dependent efficiency of
G:T mismatch repair (Sibghat-Ullah and Day, 1993; Tornaletti and Pfeifer, 1995;
Greenblatt et al., 1994). On the other hand, since cytosine methylation has been found to
be a major factor determining the strongly preferential formation of bulky DNA adducts at
CpG sites in p53 sequences (Denissenko et al., 1997), there is still a possibility that colon
cancer is caused by specific carcinogen(s) that preferentially target methylated CpGs and
cause G -> A transitions (Pfeifer and Denissenko, 1998).
The p53 mutation pattern in liver tumors is very unique in that it is dominated by
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Figure 2. Distribution of the somatic point mutations in the p53 gene in colon, liver, skin,
and lung cancers.
The horizontal axis represents the p53 codon sequence. The size of vertical bars represents
the number of mutations found at a particular codon. Indicated in each tumor type are the
total number of mutations, the major mutation type(s) at the hotspot codons, and hotspot
codon numbers. Data were obtained from the IARC p53 database (Hainaut et al., 1998).
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one hotspot, a G -> T transversion on the nontranscribed strand at the third position of
codon 249 (AGG -> AGT) (Fig. 2). There is strong evidence to suggest that this mutation
is specifically associated with dietary aflatoxin BI (AFB1) exposure (Wogan, 1992; Aguilar
et al., 1994; Montesano et al., 1997; Hussain and Harris, 1998). Although hepatitis B
virus (HBV) infection has also been associated with hepatocellular carcinomas, the
mechanism is still not clear. One hypothesis postulates that recurrent liver cell proliferation
occurring among HBV chronic carriers is the rate-limiting factor favoring the selective
clonal development of cells mutated by AFB1 in certain geographic regions (or other
exogenous or endogenous agents in other regions) (Harris and Sun, 1984). Recently, it
has been found that codon 249 is not the only damage site caused by AFB1 in the p53 gene
(Pfeifer and Denissenko, 1998), indicating that a synergistic interaction between aflatoxin
exposure and HBV infection and clonal selection may cause the observed p53 mutation
pattern in liver cancer (Greenblatt et al., 1994). It is interesting to note that in lung cancer
codon 249 is also a mutational hotspot (Fig. 2), but these mutations occur almost
exclusively at the second position of the codon (AGG -> ATG). The second position has
been found to be a target for benzo[u]pyrene (Denissenko et al., 1996). The different
substitutions within the same codon between liver and lung cancer probably reflect
differential binding of carcinogens to a given DNA sequence as well as differential repair of
the resultant DNA adducts.
The p53 mutations in skin cancer are characterized by a high prevalence (40%) of C
-> T and CC -> TT transitions at dipyrimidine sites, which incriminates ultraviolet radiation
as the major etiology of human skin cancer (Brash et al., 1991; Dumaz et al., 1994;
Nakazawa et al., 1994; Jonason et al., 1996). There are 30 dipyrimidine sites (18 on the
nontranscribed strand) in the conserved domains of the p53 gene. The distribution of C ->
T transitions among these sites is nonrandom. Mutational hotspots are found at codons
178-179, 196, 213, 245, 248, 278 and 282 (Fig. 2), with a strand bias toward the
nontranscribed strand. Furthermore, it is found that many of these hotspots (codons 196,
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213, 245, 248 and 282) occur at dipyrimidine sites containing 5-meC which also belongs
to a CpG site (Tommasi et al., 1997). The nonrandom distribution of transitions in skin
cancer has been partially explained by the slow repair of pyrimidine dimers on the
nontranscribed strand (Evan et al., 1993), and by the preferential formation and slow repair
of pyrimidine dimers at 5-meC bases (Tornaletti and Pfeifer, 1994; Pfeifer and Denissenko,
1998).
The prevalent type of p53 mutations found in lung cancer is G -> T transversion,
which comprises one-third of all missense mutations (Hernandez-Boussard and Hainaut,
1998). 93% of the transversions occur at guanine residues on the nontranscribed strand.
This mutational specificity is consistent with that of several types of chemical carcinogens
found in cigarette smoke such as benzo[a]pyrene. The most frequently mutated codons in
lung cancer are 157, 158, 179, 245, 248, 249, 273 and 282 (Fig. 2). Studies using normal
human bronchial epithelial cells have demonstrated that benzo[ct]pyrene diol epoxide
(BPDE) selectively binds to guanines in codons 157, 248 and 273 (Denissenko et al.,
1996), and that the selective occurrence of these adduct hotspots is due to an enhancement
of adduct formation by 5-meC adjacent to the target guanine at CpG sites (Denissenko et
al., 1997). It has also been demonstrated that BPDE adducts on the nontranscribed strand
of the p53 gene are repaired slower than those on the transcribed strand (Denissenko et al.,
1998). Recently, it has been shown that the p53 mutation pattern in lung cancer among
nonsmokers significantly differs from that found among smokers by a lower proportion of
G -> T transversions and a higher proportion of G -> C transversions, although the
number of nonsmokers analyzed in the study were relatively small (Hernandez-Boussard
and Hainaut, 1998).
The APC gene
The APC gene is localized on chromosome 5q21-22 and comprises 15 exons
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(Kinzler et al., 1991; Groden et al., 1991). The APC protein consists of 2843 amino acids
and is located at the basolateral membrane in colorectal epithelial cells. APC plays a central
role in controlling the cell death process by integrating signals from a variety of sources and
transmitting them to the nucleus (Kinzler and Vogelstein, 1996). The APC gene has been
identified as the gatekeeper gene of colon cancer, the mutation of which initiates the cascade
of colorectal tumorigenesis (Fearon and Volgestein, 1990).
Mutations in the APC gene have been found in over 80% of sporadic colorectal
cancer and in some cancer of the stomach, pancreas, thyroid, ovary and other primary sites
(Nagase and Nakamura, 1993; Kinzler and Vogelstein, 1996). Germline APC mutation is
the cause of familial adenomatous polyposis, an autosomal dominant precancerous
condition characterized by the appearance of hundreds to thousands of adenomatous polyps
throughout the entire colorectum. Although a database containing over 1000 somatic and
germline mutations in the APC gene is now available (Laurent-Puig et al., 1998), each
mutation in this database has been logged only once. In order to identify potential
mutational hotspots, the APC gene mutations have been re-compiled from the literature
taking into account recurrent mutations (B. Muniappan and X.-C. Li-Sucholeiki,
unpublished data). The data set which comprises 380 somatic mutations and 288 germline
mutations is shown in Fig. 3.
Over 95% of APC mutations are either frameshift or nonsense mutations leading to
a truncated protein (Laurent-Puig et al., 1998; Hussain and Harris, 1998). The restricted
types of mutations found in the APC gene do not allow for the kind of extensive
epidemiological studies as those done with the p53 gene. Nevertheless, the observations
that most nonsense mutations are C -> T transitions at CpG or CpNpG sites and that
frameshifts are small deletions at repeats of 2 - 5-bp DNA motifs (Fig. 3) suggest the
involvement of endogenous deamination and slipped mispairing mechanisms. Interestingly,
the APC somatic and germline mutational patterns are not alike (Fig. 3). The somatic
mutations are clustered in a region (codons 1286-1513) within exon 15, whereas germline
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Figure 3. Distribution of the somatic and germline mutations in the APC gene in human
tumors.
The horizontal axis represents the APC codon sequence. The size of the vertical bars
represents the number of mutations found at a particular codon. The mutation types at
hotspot codons are shown.
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mutations are scattered throughout the first half of the coding region (Miyoshi et al., 1992;
Nagase and Nakamura, 1993). The origin of this difference is unknown. It may reflect
differences in the mechanisms of mutation, repair or selection among these two different
cell types.
2.1.3. Somatic mutations in healthy humans: the hprt gene
Somatic mutations in healthy humans have been measured at four gene loci in blood
cells on the basis of altered cellular phenotypes: the hemoglobin (Hb) and glycophorin A
(gpa) genes in red blood cells, and the hypoxanthine-guanine phosphoribosyltransferase
(hprt) and HLA genes in T-lymphocytes (Cole and Skopek, 1994). The mean adult
background mutant frequencies at these loci have been determined to be 5 x 10-8 for Hb, 5
- 10 x 10-6 for hprt, 1 - 2 x 10-5 for gpa and 3 x 10-5 for HLA (Albertini et al., 1993; Cole
and Skopek, 1994). A significant increase in the mutant frequency with age has been
found for all loci (Grist et al., 1992; Cole and Skopek, 1994; Robinson et al., 1994). With
respect to detecting a broad spectrum of mutations, the hprt gene has been a particularly
useful target.
The hprt gene is a constitutive but dispensable housekeeping gene localized on the
X-chromosome. It comprises nine exons and encodes an enzyme of 218 amino acids that
phosphoribosylates hypoxanthine and guanine for purine salvage. HPRT is also able to
phosphoribosylate the purine analog 6-thioguanine (6TG) to 6TGMP which is highly
cytotoxic. Inactivating mutations in the hprt gene allow the mutant cells to grow in the
presence of otherwise toxic concentrations of 6TG, providing a convenient means for
selection. Detection and characterization of somatic hprt mutations in human peripheral
blood T-lymphocytes involves direct cloning (Albertini et al., 1982; Morley et al., 1983).
T-cells are cultured under limiting dilutions in the presence or absence of 6TG selection.
The ratio of cloning efficiency with and without 6TG defines the hprt mutant frequency.
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Mutant colonies can be isolated and propagated in vitro for the molecular characterization of
their mutations (Albertini et al., 1982; Morley et al., 1983).
It has been found that gross structural alterations are the predominant type of hprt
mutations found in newborns (85%), whereas they only account for 15% in adults
(Albertini et al., 1993). The most prevalent alterations found in newborns are due to
deletions mediated by the V(D)J recombinase. As people age, the hprt mutant frequencies
increase and the proportion of gross alterations decrease. This is presumably due to an
accumulation of endogenous and induced mutations that are not gross alterations.
A comprehensive hprt mutation database has been compiled from the literature
(Cariello et al., 1997). In combination with a recent study (Podlutsky et al., 1998), there
are nearly 500 somatic mutations that have been detected in peripheral T-lymphocytes of
healthy humans (including both smokers and non-smokers), and 130 germline mutations in
patients with Lesch-Nyhan syndrome (LNS) or gout. Table 3 shows the number and type
of somatic mutations found in the coding region of the hprt gene. Single base-pair
substitutions are the most common mutations observed which constitute 58% of the total.
One percent are tandem base substitutions. Deletions and insertions (including frameshifts)
account for 37% of the total mutations. The remaining 4% are complex mutations. Among
the single base-pair substitutions, mutations at GC base pairs (61%) are more prevalent
than mutations at AT base pairs (39%), despite the fact that there are fewer mutable GC
base pairs (48%) than AT base pairs (Podlutsky et al., 1998). The majority of the
mutations at GC base pairs (71%) occurred at guanines on the non-transcribed strand. G/C
-> A/T is the most common type of base-pair substitution (35%).
There are eight CpG sites in the hprt coding region, the methylation status of which
is still unknown (Podlutsky et al., 1998; O'Neill and Finette, 1998). Among the single
base-pair substitutions in the hprt gene, transitions at CpG sites account for 6.6% (18/27 1)
of all somatic mutations (at basepairs 142, 151 and 508), and 14% (14/96) of all germline
mutations (at basepairs 142, 151, 481 and 508) (O'Neill and Finette, 1998; Podlutsky et
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Table 3. Number and type of somatic mutations in the coding
region of the hprt gene in healthy humans.
Tandem substitution
Frameshift
+1 bp
-1 bp
Deletion
3-52bp
> 52 bp
Insertion
Complex
Total
(a) Number in parentheses represents the percentage of each
type of substitution among the total single base-pair substitutions.
(Data were obtained from Cariello et al., 1997 and Podlutsky,
1998).
Type of mutation
Single base-pair substitution
Transition
G -> A
C ->T
A ->G
T ->C
Transversion
G ->T
C ->A
G ->C
C ->G
A ->T
T ->A
A ->C
T ->G
Mutation at AT
Mutation at GC
No. of mutation
271
127
62
33
14
18
144
28
2
27
13
18
21
4
31
106
165
5
35
8
27
134
12
122
4
18
467
% of total
58 (100)a
(47)
(23)
(12)
(5)
(7)
(53)
(10)
(1)
(10)
(5)
(7)
(8)
(1)
(11)
(39)
(61)
1
7
1
6
29
3
26
1
4
100
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al., 1998). Therefore, it has been concluded that transition mutations at CpG dinucleotides
are the most frequent hprt germline and somatic mutations, implicating endogenous
deamination as the major mutagenic mechanism involved in hprt mutation in vivo (O'Neill
and Finette, 1998).
The distribution of the point mutations in the hprt gene is non-random (Fig. 4). It
has been estimated that there are > 300 mutable sites in the hprt coding region where
mutations are expected to give rise to a selectable phenotype (Cariello and Skopek, 1993).
Among the mutational hotspots (with 4 or more mutations at a single site), base pairs 197,
508 and 617 are the three most prominent ones (Fig. 2). Nearest neighbor analysis has
shown that the mutated guanine at basepair 197 is preceded by a CTC-trinucleotide which
is the vertebrate topoisomerase I consensus cleavage site (CTC or CTT) (Podlutsky et al.,
1998). This consensus sequence has been implicated in single base-pair substitutions at
other positions (such as basepairs 143 and 146) (Podlutsky et al., 1998). All mutations at
basepair 508 are C -> T transitions at a CpG site. Basepair 617 involves a (TG)2-repeat.
It has been shown that most of frameshifts and small deletions occur in a sequence
context of mononucleotide runs, short di- or trinucleotide repeats, or invert repeats, which
resembles certain polymerase arrest sites, symmetric elements, and the consensus cleavage
sequence for vertebrate topoisomerase I (Podlutsky et al., 1998).
Taken together, the present spectrum of hprt somatic mutations does not seem to
pinpoint any particular kind of exogenous agent as the cause for these mutations. The
observations of the same set of mutational hotspots in different human populations have led
to the postulate that in vivo mutations in the hprt gene are endogenous in origin or induced
by ubiquitous environmental exposures (Burkhart-Schultz et al., 1996; Podlutsky et al.,
1998). The spectra of hprt somatic mutations in both smokers and non-smokers have been
compared. So far, no statistically significant differences have been observed between the
two subpopulations (Vrieling et al., 1992; Burkhart-Schultz at al., 1996).
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Figure 4. Distribution of the somatic and germline point mutations in the hprt gene in
human T-lymphocytes in vivo.
Data were obtained from Cariello et al., 1997 and Podlutsky et al., 1998. The horizontal
axis represents the hprt coding sequence. The size of the vertical bars represents the
number of mutations found at any one particular basepair. The types of mutations of the
mutational hotspots and the neighboring sequence contexts are shown as indicated. *
indicates CpG sites.
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2.2. Current methods for detecting point mutations
Detection of point mutations has become central to human genetic analysis, such as
diagnosis of genetic diseases, discovery of disease-associated genes and identification of
the causes of human mutation. These studies require effective methods that can permit rapid
screening for mutations in a large number of genes and detection of rare mutants against the
background of an excess of wild-type sequence. This section reviews the current methods
for detection of point mutations with respect to their principles, sensitivities, applications
and limitations (Fig. 5).
2.2.1. Single-strand conformation polymorphism (SSCP)
SSCP identifies most sequence variations in single-strand DNA molecules based on
their differential electrophoretic mobilities in a non-denaturing polyacrylamide matrix (Orita
et al., 1989). Under nondenaturing conditions, a DNA single-strand will adopt a
conformation (presumably through internal base-pairing between short segments) that is
uniquely dependent on its sequence composition. This conformation is usually different
even if only a single base has been changed. Most conformations seem to alter the physical
configuration so that the configuration-to-charge ratio is different enough to cause a
mobility difference upon electrophoresis through a polyacrylamide gel.
Typically, PCR is first performed to amplify the analyzed sample with possible
genotypic differences. The diluted PCR products are then denatured into single strands and
loaded on a nondenaturing polyacrylamide gel. The SSCP single strands are detected using
autoradiography of 32 P incorporated during PCR as 3 2 P-labeled primers or
deoxynucleotide triphosphate substrates, or by silver or ethidium bromide staining of the
SSCP gels (Sekiya, 1993; Ainsworth et al., 1991). The detection efficiency for single base
substitutions by SSCP has been reported to be more than 90% in fragments equal to or less
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Figure 5. Current methods for detection of point mutations.
The sensitivities of the methods are here presented in relation to the sensitivities required
for various applications. The sensitivity for each method refers to the reported lowest
mutant fraction that can be detected by the method as reported in the literature.
Abbreviations are given in the text. Dash line (--) indicates data not available.
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than 300-bp in length (Sekiya, 1993; Fan et al., 1993). Recently the conventional slab gel
analysis of SSCP has been replaced by capillary electrophoresis with laser-induced
fluorescence detection using linear polyacrylamide matrices, which has greatly increased
the speed and efficiency of this detection method (Katsuragi et al., 1996; Ren et al., 1997;
Wenz et al., 1998).
The PCR-SSCP analysis has been widely used in screening for mutations
associated with cancers and inherited diseases (Suzuki et al., 1990; Groden et al., 1990;
Kishimoto et al., 1992; Mashiyama et al., 1991; Katsuragi et al., 1996; Ren et al., 1997;
Wenz et al., 1998; Humphries et al., 1997). The advantage of this technique is the large
target size that can be scanned at any one time. The disadvantage is its limited sensitivity in
detecting minor mutant alleles among mixed cell populations, which has been reported to be
1 in 4 to 1 in 33 (Suzuki et al., 1990; Wu et al., 1993; Hongya, et al., 1993).
2.2.2. Restriction fragment length polymorphism (RFLP)
RFLP (or restriction site mutation assay) detects mutations that alter a restriction
endonuclease recognition sequence (Pourzand and Cerutti, 1993a; Steingrimsdottir et al.,
1996; Jenkins et al., 1998). Digestion with a chosen restriction enzyme cleaves the wild-
type recognition sequence but leaves mutated sites intact. The uncut fragments are then
amplified by PCR with primers flanking the restriction sites. Mutants are then identified
and quantified by cloning and oligonucleotide-specific hybridization. A known number of
copies of "mutant standard" is usually added to the cellular DNA prior to the digestion
procedure for later data calibration and estimation of the absolute mutation frequencies
(Sandy et al., 1992; Chiocca et al., 1992).
The sensitivity of this approach varies from study to study and the restriction sites
analyzed. The highest sensitivity has been reported to be in the range of 10-8 to 10-6
(Pourzand and Cerutti, 1993a). The primary limitation on the sensitivity of this approach is
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the efficiency of the restriction digestion step. Not every restriction site can be analyzed
because restriction enzyme digestion does not always approach completeness. In this
regard, Taq I endonuclease is considered to be particularly well-suited for this assay
(Sandy et al., 1992; Chiocca et al., 1992). The thermostability of Taq I endonuclease
allows for the continuous digestion of the residual wild-type sequence before, during, and
after PCR. A secondary limitation on the sensitivity of this approach is the inherent error
rate of the DNA polymerase at any particular base pair in PCR. High-fidelity polymerase
such as Pfu DNA polymerase has been used to increase the sensitivity of the assay
(Pourzand and Cerutti, 1993b). Additional factors affecting the performance of the assay
include certain types of DNA damage that block restriction digestion and are later converted
into mutations during PCR (Steingrimsdottir et al., 1996).
The RFLP/PCR approach has been applied to detecting mutations in two Msp I
sites in codons 11 and 12 of the human c-H-ras 1 gene (Pourzand and Cerutti, 1993b;
Amstad and Cerutti, 1995), Msp I and Hae III sites in codons 247-250 of the human p53
gene (Aguilar et al., 1993; Hussain et al., 1994a; Hussain et al., 1994b), an Mni I site in
rat H-ras codon 12 (Lu and Archer, 1992), a Taq I site in exon 2 of the human c-H-ras 1
gene (Chiocca et al., 1992), and a Taq I site at the aprt gene of Chinese hamster cells
(Steingrimsdottir et al., 1996). In these studies, mutational hotspots were detected at these
restriction sites in cells treated with various mutagenic agents including N-methyl-N-
nitrosourea (MNU), N-ethyl-N-nitrosourea, ethyl methanesulphonate, 4-nitroquinoline-1-
oxide, AFBi and oxidative radicals. This approach has also been applied toward
measuring the frequency of mutations in the p53 gene in normal human liver samples from
different geographical regions that differs in the level of dietary AFB1 exposure (Aguilar et
al., 1994). The frequency of the AGG to AGT mutation at codon 249 in the samples was
found to range from 2 - 13 x 10-7 in the low exposure regions to 0.5 - 1.8 x 10-5 in the
high exposure region. The results support the hypothesis that AFB1 is a causative mutagen
in liver cancer (Aguilar et al., 1994).
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Although the RFLP/PCR approach has a very high detection sensitivity, it is
constrained in that not every gene sequence of interest encompasses a restriction enzyme
cleavage site and that the target size is limited to 4 - 6 base pairs for each assay.
2.2.3. Allele-specific PCR (ASP)
ASP detects specific point mutations based on preferential PCR amplification of the
rare mutant allele over the wild-type allele. The strategy is to use an oligonucleotide primer
that has fewer 3' mismatch(es) with the mutant allele than with the abundant wild-type
allele (Bottema and Sommer, 1993). Synonymous terms for this technique in the literature
include Allele-Specific Amplification (ASA), PCR Amplification of Specific Alleles
(PASA), Amplification Refractory Mutation System (ARMS) and Mismatch Amplification
Mutation Assay (MAMA). ASP requires the use of a DNA polymerase, generally Taq
polymerase, that lacks a 3' -> 5' exonuclease activity since such activity would remove the
3-terminal mismatch(es). The amplified products are then analyzed by gel electrophoresis,
and then detected by autoradiography of 32P incorporated as labeled deoxynucleotide
triphosphate substrates in PCR (Cha et al., 1992), or by staining the gel with ethidium
bromide or SYBR green (Sarkar et al., 1990; Chen and Zarbl, 1997).
The reported sensitivity of ASP varies from 2.5 x 10-2 to 2 x 10-6 in the literature
(Sarkar et al., 1990; Cha et al., 1992; Chen and Zarbl, 1997). To establish an ASP assay
with a high sensitivity requires optimization of a variety of parameters including the
mismatch primer sequence; the temperature of the primer extension step; the time permitted
for extension; and the composition of the reaction mixture, particularly the concentrations
of dNTP, MgCl2, primer and glycerol (Cha et al., 1992). It has been shown that five
mutant alleles among 3 x 106 copies of wild-type alleles can be detected through the use of
Stoffel fragment coupled with two rounds of PCR (Chen and Zarbl, 1997).
The ASP approach has been widely applied to population screening for single base-
47
pair substitutions in genes associated with genetic diseases. These genes include the
phenylalanine hydroxylase gene associated with phenylketonuria (Sommer et al., 1989),
factor IX gene associated with hemophilia (Sarkar et al., 1990), apolipoprotein B gene
associated with hypercholesterolemia (Ruzicka et al., 1992), and mitochondrial DNA
associated with neuromuscular disease (MUnscher et al., 1993; Zhang et al., 1993; Seibel et
al., 1993). In these studies, the detection sensitivity has been reported to be around 10-2.
Using MAMA, Cha et al. (1994) were able to detect spontaneous mutations at a frequency
of 10-5 in codon 12 of the rat H-ras gene and showed that MNU-induced rat mammary
tumors arose from preexisting H-ras mutations.
Although it can reach a high level of sensitivity, the major limitation of ASP is that
only one specific point mutation can be detected at any one time.
2.2.4. Blocker-PCR
Blocker-PCR detects point mutations based on the preferential amplification of the
mutant alleles through the use of a pair of oligonucleotide primers that match both strands
of the wild-type sequence but not the mutants (Seyama et al., 1992). These blocker primers
contain 3'-terminal dideoxynucleotide so that they cannot be extended during PCR, and
also block polymerase elongation of a pair of amplification primers that flank at the 5' side
of each of the blocker primers. Conditions are chosen so that binding of the blocker
primers to sequences containing a mutation in the binding region is not favored. Therefore
the mutant sequence can be preferentially amplified using the pair of amplification primers.
By linking this approach to SSCP, Seyama et al. (1992) were able to detect mutations in a
human N-ras gene at a frequency of 10-4 - 10-3. The advantage of blocker-PCR is its
relatively large target size. Any base substitution at a number of positions is detectable as
long as it destablizes the hybridization of the blocker-primers.
A modification of the blocker-PCR technique is peptide nucleotide acid (PNA)-
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mediated PCR clamping (Thiede et al., 1996). In this approach, a PNA primer is used as a
blocker primer to cover the target site. One of the amplification primers overlaps with the
PNA primer sequence but does not include the target sequence. Because PNA:DNA
duplexes are more stable than DNA:DNA duplexes, the PNA primer will bind to the wild-
type sequence more strongly than the amplification primer and suppress the amplification of
the wild-type allele during PCR. If the target sequence is mutated, the binding of the
amplification primer will be favored over that of the PNA primer and provide selective
amplification of mutant alleles. This approach alone has been shown to have a sensitivity of
5 x 10-2 (Thiede et al., 1996). By combining this approach with SSCP analysis, Behn et
al. (1998) were able to increase the sensitivity 10 - 50-fold in detecting point mutations at
codons 248, 249 and 273 of the p53 gene.
2.2.5. Ligase chain reaction (LCR)
As ASP and blocker-PCR, LCR also detects point mutations based on preferential
amplification of the mutant alleles, but using a different strategy. In LCR, two pairs of
synthetic oligonucleotides, which are designed to hybridize at adjacent positions to the
complementary strands of the desired mutant allele, are joined by a thermostable ligase.
Multiple rounds of denaturation, annealing and ligation result in the exponential
amplification of the mutant allele. Since a mismatch at the ligation joint severely reduces
the efficiency of ligation, other sequences (including the wild-type) that differ by a single
base pair are discriminated (Barany, 1991). By using allele-specific oligonucleotides that
differ in length, LCR can be used to detect multiple substitutions at a single position
(Barany, 1991). Different approaches are available to detect and quantify the ligated
product. Oligonucleotide primers can be labeled with 32 P, fluorescent dyes, digoxigenin,
or biotin, and the ligated product monitored by size using gel electrophoresis (Barany,
1991; Kalin et al., 1992; Wiedmann et al., 1993). The sensitivity of LCR is typically less
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than 10-2 due to the generation of target-independent ligation products. This occurs when
complementary primers form duplex molecules having blunt-ends which can then be ligated
(Wiedmann et al., 1993).
Several improvements have been made to increase the sensitivity of LCR. One of
them is Gap-LCR, which uses complementary probe pairs containing 3' extensions
(Abravaya et al., 1995). After hybridization to the target DNA, a gap of one to several
bases forms between adjacent probes. A thermostable DNA polymerase (devoid of 3' ->
5' exonuclease activity) and the appropriate nucleotide(s) are then used to fill the existing
gap so that the extended probes can be jointed by DNA ligase. The use of probe duplexes
with non-complementary 3' extensions prevents the generation of target-independent
ligation products. In combination with an immunoassay system for detection of the
amplification products, Gap-LCR has been applied to the detection of a human
immunodeficiency virus (HIV) mutation associated with AZT resistance with a sensitivity
of 10 -4 (Abravaya et al., 1995).
The limitation of the LCR method is that mutations occurring at only one specific
base-pair can be detected at any one time.
2.2.6. MutS-based assays
Recently several approaches to mutation detection have been developed based on
the selective binding property of the Escherichia coli (E. coli) mismatch binding protein
MutS to DNA molecules containing mismatched bases (Ellis et al., 1994; Lishanski et al.,
1994; Wagner et al., 1995; Smith and Modrich, 1996; Parsons and Helflich, 1997a). This
binding can be detected utilizing the gel mobility-shift assay (Lishanski et al., 1994), the
MutH-, MutL-, and MutS-dependent d(GATC) cleavage reaction (Smith and Modrich,
1996), or the binding-dependent protection from exonuclease digestion assay (Ellis et al.,
1994). For example, the MutS/exonuclease (MutEx) assay (Ellis et al., 1994) was initially
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developed to map allelic variants in exon 11 of the cystic fibrosis transmembrane regulator
gene. Heterozygous or homozygous PCR products were first generated from individuals
who were mutant or wild-type for an analyzed gene fragment. The PCR products were then
incubated with MutS and treated with T7 DNA polymerase containing 3' -> 5' exonuclease
activity. The heteroduplexes bound to MutS were blocked from the exonuclease digestion,
and thereby the length of the product indicated the position of the mutation.
The MutEx assay was later adapted to screening pools of alleles for a known but
rare mutation (C -> A) at codon 61 of the mouse H-ras gene (Parsons and Helflich,
1997a). The sample was denatured and reannealed to convert the rare mutant alleles into
heteroduplexes in the presence of an abundant wild-type allele, and subjected to the MutEx
selection step. The MutS-protected sequences were amplified by PCR. A single nucleotide
primer extension (SNuPE) was then performed to identify the mutant and wild-type base.
The overall sensitivity of this MutEx/PCR/SNuPE approach was determined to be 2 x 10-5 .
Since the sensitivity of SNuPE alone is between 1 in 5 and 1 in 50, it was been determined
that MutEx assay was able to enrich the mutant sequence approximately 1000-fold (Parsons
and Helflich, 1997a). The use of SNuPE, however, limits this approach to detecting
mutations at one base-pair at a time. Recently, through a combination of mutant enrichment
by MutEx (using the thermostable Thermus aquaticus MutS protein) and allele-specific
competitive blocker-PCR (ACB-PCR), the detection sensitivity of the codon 61 mutation
has been reported to reach 1 x 10-7 (Parsons and Heflich, 1998).
It has been shown that MutS immobilized to a solid support exhibits an enhanced
ability to discriminate between DNA with and without mismatches as compared to MutS in
solution (Wagner et al., 1995). In a reconstruction experiment, mixtures of mutant and
wild-type DNA were amplified by PCR using 5'-biotinylated primers. Heteroduplex
molecules in the PCR products were then captured by the MutS-coated paramagnetic beads.
Using a colorimetric assay based on the biotin-label, it was shown that mutant fractions as
low as 10-3 could be measured (R. Wagner, unpublished results).
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The sensitivity of the MutS-based assays is limited by the background binding of
MutS to wild-type homoduplexes. These assays have so far only been carried out in model
experiments. The major disadvantage of using MutS in mutation detection is that MutS has
different binding affinities for different types of mismatched bases (Su and Modrich, 1986;
Babic et al., 1996). This would make it difficult to measure the frequencies of unknown
mutations. In addition, it has been shown that MutS binds several types of DNA lesions
(Rasmussen and Samson, 1996; Duckett et al., 1996). These lesions, after being enriched
by MutS, could be converted into mutations during PCR and give rise to false signals. The
reliability and applicability of the MutS-based assays in detecting rare mutations in
biological samples remains to be demonstrated.
2.2.7. Denaturing gradient gel electrophoresis (DGGE) and constant denaturant gel
electrophoresis (CDGE)
DGGE and CDGE separate double-stranded DNA differing by single base
substitutions based on the same theory: DNA cooperative melting equilibrium (Fischer and
Lerman, 1983). According to this theory, the melting of a DNA fragment is a stepwise
process with each melting domain of the fragment melting as a single unit at a particular
denaturing condition. If a DNA fragment consists of two domains, one domain has a
higher melting temperature (Tm) than the other, then within a certain range of denaturing
conditions, the low melting domain of the DNA fragment will melt while the high melting
domain remains intact. This partially melted form, which exists in a rapid equilibrium with
the unmelted form, has a reduced mobility upon electrophoresis as it travels through a
polyacrylamide matrix. The overall mobility of the DNA fragment therefore depends on the
stability of its low melting domain, which in turn is extremely sequence dependent. It has
been shown that even single base-pair variations in the low melting domain have an altered
Tm allowing for their separations by gel electrophoresis under appropriate denaturing
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conditions. The technique is even more effective for separating mutant/wild-type
heteroduplexes from wild-type homoduplex DNA because a single mismatch will
dramatically destablize the low melting domain (Thilly, 1985). The addition of a GC-clamp
(which is an artificial high melting domain) to the end of a DNA fragment permits analysis
of any DNA sequence (Myers et al., 1985b; Sheffield et al., 1989). The advantage of the
technique is the large target size (100 - 150-bp) that can be scanned at once.
DGGE employs a linear gradient of urea/formamide in a polyacrylamide gel matrix
such that the DNA migrates into an increasing concentration of denaturant. The molecule
travels through the gel in the helical form until it reaches the concentration of denaturant at
which its low melting domain becomes single-stranded resulting in a great reduction in the
mobility of the fragment. After electrophoresis, mutations that have a higher or lower Tm
than that of the wild-type DNA will be found respectively at a higher or lower concentration
of denaturant in the gel, i.e., below or above the position of the wild-type DNA.
In combination with PCR, DGGE has been widely used in screening for unknown
point mutations associated with tumors and other genetic diseases (Myer et al., 1985a;
Kogan and Gitschier, 1990; Higuchi et al., 1991; Weinstein et al., 1990; Newmark et al.,
1992). Another important application of the PCR/DGGE approach has been the analysis of
entire populations of mutants in a given segment of a phenotypically selectable gene such as
the human hprt gene (Thilly, 1985; Keohavong and Thilly, 1992a). In this approach, 104
- 105 HPRT- mutants are generated in vitro through the treatment of cultured human cells
with a mutagenic agent. The selective agent, 6TG, is added to the bulk culture. Mutants
induced by the treatment will eventually overgrow the culture. The genomic DNA is
isolated from the complex mutant population. The target sequence is then amplified by
PCR and analyzed by DGGE. The DNA bands in the gel are detected using
autoradiography of 32P incorporated during PCR as 32 P-labeled primers. Mutant bands are
then individually extracted, purified and sequenced. This approach has been applied to
determining the mutational spectra of a variety of genotoxicants, including MNNG, ICR-
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191, ultraviolet light, oxygen, hydrogen peroxide, BPDE, cisplatin, X-rays, 4-
nitroqinoline-1-oxide, chromium (VI), and AFB1 (Cariello et al., 1990; Keohavong et al.,
1991; Oller and Thilly, 1992; Keohavong and Thilly, 1992a; Keohavong and Thilly,
1992b; Cariello et al., 1992; Okinaka et al., 1993; Cariello and Skopek, 1993; Chen and
Thilly, 1994; Cariello et al., 1994). The detection sensitivity of this approach is about 10-2,
although detection of a mutant fraction at 10-3 has been reported in a reconstruction
experiment (Keohavong and Thilly, 1992b).
Several improved protocols of DGGE have been reported to optimize the detection
of point mutations. In the double-gradient DGGE technique, a secondary porosity
gradient, typically 6.5 - 12% polyacrylamide, is colinearly superimposed to the primary
denaturing gradient (Cremonesi et al., 1997; Gelfi et al., 1997). With the help of this
secondary sieving gradient, some heteroduplex molecules, which often produce smeared
and diffuse bands on conventional DGGE (due to a lack of a sharp melting transition), are
recompacted into remarkably narrow bands. Double-gradient DGGE has been also shown
to improve the resolution between two homoduplex bands. This technique has been
applied to the analysis of point mutations in several exons of the cystic fibrosis
transmembrane conductance regulator gene as well as in exons 6 and 8 of the p53 gene in
tumor specimens (Cremonesi et al., 1997; Gelfi et al., 1997).
Other improvements have recently been made to facilitate the analysis of very GC-
rich sequences that cannot normally be analyzed by conventional DGGE due to the strand
dissociation phenomena (Guldberg et al., 1998). It has been shown that treatment of
template DNA with sodium bisulphite drastically lowers the melting temperature of GC-rich
sequences and renders them amenable to DGGE analysis. The use of this bisulphite DGGE
technique has been demonstrated in the rapid and efficient detection of mutations in the p16
(INK4/CDKN2) tumor suppressor gene (Guldberg et al., 1998).
CDGE is a modification of DGGE in which a specific denaturing concentration is
used allowing for a maximal separation between the wild-type and mutant sequences
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(Hovig et al., 1991). In DGGE, the continual movement of partially melted molecules into
an increasingly higher concentration of denaturant can give rise to new molecular
configurations which may result in loss of resolution as running times are extended. By
contrast, in CDGE, DNA molecules which differ by a single base change migrate at
consistently different mobilities causing the resolution to behave as a simple function of the
distance traveled. It has been shown that when operated under optimal denaturing
condition (which corresponds to the steep parts of the profile observed in DGGE), CDGE
can provide an increased resolution as compared to DGGE (Hovig et al., 1991; Ridanpha et
al., 1995). CDGE in combination with PCR has been applied to the rapid screening for
mutations in the p53 and BRCA] genes in a large numbers of cancer patients (Borresen et
al., 1991; Andersen et al., 1998).
2.2.8. Constant denaturant capillary electrophoresis (CDCE)
CDCE combines the separation principles underlying CDGE with capillary
electrophoresis (CE) which uses laser-induced fluorescence detection and replaceable linear
polyacrylamide matrices (Khrapko et al., 1994b). The denaturing conditions in CDCE are
achieved through temperature elevation of a section of the capillary which is inserted into a
temperature controlled water-jacket. In comparison to slab gel electrophoresis, CDCE
offers higher resolution, sensitivity and speed, as well as on-line detection and an
amenability to automation.
By coupling high-fidelity PCR with the techniques of CDGE and CDCE for
enrichment of mutants, an approach has been developed to measure point mutational
spectra in a 100-bp mitochondrial DNA sequence (mitochondrial bp 10,030-10,130) in
human cells and tissues (Khrapko et al., 1997a). In this approach, mitochondrial mutant
sequences in the digested genomic DNA are first separated from an excess of wild-type
sequence by CDGE in their homoduplex forms. CDGE is used at this stage because of its
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relatively large sample loading capacity. Through CDGE the high and low Tm mutants
(mutants with melting temperatures higher and lower than that of the wild-type
homoduplex, respectively) are enriched separately by extracting DNA from the gel blocks
above and below the position of the wild-type homoduplex. The efficiencies of mutant
enrichment have been found to be 100 to 200-fold for the high Tm mutants and 5 to 10-fold
for the low Tm mutants. The mutant-enriched samples are then subjected to high-fidelity
PCR using native Pfu DNA polymerase. At the end of the PCR reaction all of the rare
mutants are converted into heteroduplexes with the wild-type sequence. The PCR products
are then separated by CDCE. The heteroduplex fraction is collected to further enrich the
mutants over 20-fold and then amplified by a second round of high-fidelity PCR. The
mutants are then finally separated on CDCE in their homoduplex forms. Individual
mutants are then purified and sequenced. The frequency of a mutant in the original sample
is measured by comparing the peak area of the mutant with that of the internal standard.
The detection limit of this approach when applied to measuring mitochondrial mutational
hotspots in human cells has been determined to be 10-6 for the high Tm mutants and 10-5
for the low Tm mutants (Khrapko et al., 1997a).
The above mutational spectrum analysis has been applied to several healthy human
tissues including colon, muscle and lung, their derived tumors, and human lymphoblastoid
TK6 cells grown in culture (Khrapko et al., 1997b). In the lung study, bronchial epithelial
cells from smoking and nonsmoking twins were also compared (Coller et al., 1998). A set
of seventeen hotspots, predominately G:C -> A:T and A:T -> G:C transitions, have been
identified in the 100-bp mitochondrial target sequence with mutant fractions ranging from
10-5 to greater than 10-4 in the analyzed human tissues (Fig. 6). Remarkably, the same set
of point mutational hotspots have been observed in all of the samples investigated. Several
tests have been performed to verify the true existence of the 17 hotspots in the analyzed
samples (Khrapko et al., 1997a; Khrapko et al., 1997b). The observations of the same set
of mutants in different organs and in cultured cells have led to the conclusion that
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mitochondrial point mutations in the tissues and sequence studied are spontaneous in origin
(Khrapko et al. 1997b).
This same approach has also been applied to the analysis of chemically-induced
mutational spectra in the 100-bp mitochondrial sequence in MT1 cells (Marcelino et al.,
1998). The TK6-derived MT1 cells, which are highly resistant to MNNG cytotoxicity but
remains sensitive to MNNG mutagenicity, were treated with a high dose (4 gM) of
MNNG. A set of seven G:C->A:T transitions at frequencies ranging between 6 x 10-5 and
3.0 x 10-4 were reproducibly observed in the treated cells and were found distinct as
compared to spontaneous background mutations (Fig. 6). Interestingly, when MTI cells
were repeatedly treated with a maximum tolerated dose (0.4 gM) of BPDE, no induced
mitochondrial mutations were observed (Marcelino et al., 1998). These results
demonstrated that an exogenous mutagen can induce detectable mutations in the human
mitochondrial DNA. However, such observations seem only possible when a specific cell
line which is resistant to a mutagen's toxicity is treated with an extremely high dose of the
given mutagen which far exceeds the tolerance of normal cells. These results further
support the previous conclusion that spontaneous mutagenic processes are the predominate
causes of human mitochondrial mutation. These studies suggest that the mitochondrial
DNA, due to its high level of spontaneous background mutations, may not be an
appropriate target for biomonitoring the effect of environmental and occupational exposure
on human mutation.
Due to its high sensitivity and ability to scan a large target size, the CDCE/high-
fidelity PCR approach has been shown to be the most powerful method currently available
for detecting low frequency point mutations.
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Figure 6. The kinds, positions, and frequencies of hotspot mutations observed in the 100-
bp mitochondrial DNA target sequence (mitochondrial bp 10,031-10,130).
The horizontal axis represents the base pair position of the mitochondrial DNA target
sequence. The positions of the two genes encoded by this sequence, tRNAgIY and NADH
dehydrogenase subunit III, are shown as indicated. a, The set of hotspot mutations in
human tissues. The height of each vertical bar represents the average mutant fraction of
each mutant in most of the lung samples analyzed. Note that mutants 1 and 2 are different
substitutions at the same bp. b, MNNG-induced hotspot mutations in MTl cells. "*" and
"#" indicate identical sites of mutation in the two mutational spectra.
(Adapted from Marcelino et al., 1998)
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2.3. MNNG mutagenesis
MNNG is a well-studied simple monofunctional alkylating agent. This section
briefly reviews: (1) the current knowledge of the mutational consequences of DNA lesions
induced by MNNG; (2) the cellular repair mechanisms; and (3) the influence of the local
DNA sequence and the efficacy of repair on the distribution of the lesions and the observed
mutational spectrum.
2.3.1. The MNNG-induced DNA lesions and their mutagenic potentials
MNNG is not naturally occurring in the environment. It was first synthesized in
1947 through the nitrosation of N-methyl-N'-nitrosoguanine in cold acid medium (McKay
and Wright, 1947). Since the discovery of its mutagenic activity in 1960, MNNG has
become one of the most widely used chemical mutagens. MNNG interacts with DNA via
cationic methyldiazonium intermediates through an SNI reaction mechanism. It methylates
cellular DNA at positions Ni-, N3-, N7-adenine (A), N3-, N7-, 0 6-guanine (G), N3-, 02_
cytosine (C), N3-, 02_, 0 4-thymine (T), and the phosphate (diester) group (Beranek,
1990). Table 4 summarizes the kinds of DNA methylation adducts that are induced by
MNNG and their half-lives in vitro and in vivo (Goldmacher et al., 1986; Beranek, 1990).
Adducts that have only been identified in synthetic homopolyers (at N6-A, N4-C and N2_
G) are excluded here.
The N7 position of G represents the principle nucleophilic center in DNA. It is not
surprising that N7-meG accounts for about 70 - 80% of the total methylation produced by
MNNG in DNA (Lawley and Orr, 1970; Lawley, 1976; Goldmacher et al., 1986). The
mutagenic contribution of N7-meG had been overlooked because the lesion was not
thought to be misinstructional nor replication arresting (Abbott and Saffhill, 1979; Swann
and Magee, 1968; Loveless, 1969). However, alkylation at N7 can increase the rate of
NH 2
N
dR
NH 2
N!
N N
dR
0
3H
ONN
H2N N
dR
H*-.N3 4 CH3
d N
Table 4. MNNG-induced DNA methylation adducts in vitro and in vivo.
| Percentage of total adducts (%) | Half-life (hours)
Site of in vitro in vivo in vitro in vivo
methylatio bacterial human cells rat liver 
_ human cells! rat liver
Adenine
NI- 1.0 - < 0.2% -- - - -
N3- 12.0 2.0 2.9 8.6 17-38 <1 2-19
N7- -- - 3.4 - - 13 7
Cytosine
o2 - - -- - - - -- < 5
N3- 2.0 -- -- - -- - --
Guanine
N3- -- -- 9.7 -- - 19 17
o6- 7.0 11.0 9.2 9.2 24 20 5-72
N7- 67.0 78.0 74.8 82.2 105-192 17 29-72
Thymine
o2- -- - -- -- -- -- 12
N3- _ _ _ _ _ _ 2
o4--- - - -- - -5
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depurination by as much as six orders of magnitude through the labilization of the N-
glycosylic bond (Loeb and Preston, 1986). The half-life of this process in vitro (at neutral
pH and at 37'C) has been estimated to be between 105 and 192 hours (Singer, 1979). The
resultant apurinic (AP) sites are mutagenic (Kunkel, 1984; Loeb and Preston, 1986;
Hevroni and Livneh, 1988). In addition, N7-meG is subject to imidazole ring opening to
yield a formamidopyrimidine (Fapy) product, which blocks in vitro replication (Boiteux
and Laval, 1983; O'Connor et al., 1988). Thus, N7-meG alone may be of significant
biological importance by virtue of its relative abundance.
N3-meA represents one of the most frequently found minor products of MNNG-
induced DNA methylation. Although no miscoding property has been found for N3-meA
(Saffhill and Abbott, 1978), the methyl group of N3-meA labilizes the N-glycosylic bond
so that this base is rapidly lost from the DNA. Its half-life in vitro is between 17 and 38
hours (Singer, 1979). In addition, the act of DNA glycosylase on N3-meA produces AP
sites as intermediates in alkylation repair (Riazzudin and Lindahl, 1978). The mutagenicity
of N3-meA in E. coli is SOS dependent and include transversion (Foster and Eisenstadt,
1985).
N3-meG does not appear to block replication (Larson et al., 1985). Although it has
yet to be convincingly demonstrated in vivo, both 0 2 -meC and 0 2 -meT have been
implicated to have potential miscoding properties (Singer, 1986).
0 6-meG represents the most important DNA lesion with respect to the induction of
gene mutation and cancer by simple alkylating agents. Since the late 1960s, it has been
commonly believed that the amount of 0 6-meG in DNA and the rate of its excision
decidedly influences the frequency of induced GC -> AT transition mutation and organ
susceptibility to tumor induction (Loveless, 1969; Schendel and Robins, 1978; Singer,
1979; Newbold et al., 1980; Pegg, 1984). 0 6-meG is capable of mispairing with thymine
in both in vitro and in vivo site-specific mutational systems (Mehta and Ludlum, 1978;
Abbott and Saffhill, 1979; Loechler et al., 1984; Eadie et al., 1984; Bhanot and Ray,
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1986). It is stable in DNA in vitro at physiological pH (Gichner and Veleminsky, 1982).
0 4 -meT is the second most effective premutagenic DNA lesion produced by
MNNG. Suggested in studies on methylation induced mutation, 0 4-meT can give rise to
AT -> GC transition mutations by mispairing with guanine (Preston et al., 1986;
Richardson et al., 1987b).
Why 0 6 -meG and 0 4 -meT prefer to mispair remains unclear. It may reflect
preferential hydrogen-bonding capability, or the Watson-Crick alignment of the 0 6-meG:T
and 0 4-meT:G mispair may facilitate formation of the phosphodiester links on both the 3'
and 5' side of the incoming base during DNA replication (Swann, 1990). Other alternative
mechanisms for the mutagenic consequences of 0 6 -meG and 0 4 -meT have also been
suggested. For example, polymerase might mistake 0 6-meG in the template strand for
adenine and 0 4-meT for cytosine, due to the physical similarity of these bases (Yamagata et
al., 1988). 0 6 -meG may protonate its cytosine complement as a consequence of base-
pairing. If so, GC -> AT transition may result from the increased likelihood of this
cytosine to deaminate to uracil (William and Shaw, 1987). DNA glycosylases may repair
0 2-meT resulting in AP sites, which induce preferentially AT -> GC transitions (McCarthy
et al., 1984; Kunkel, 1984). And lastly, 0 6-meG in the methylated nucleotide pools could
incorporate at a position opposite to a thymine residue on the template strand (Toorchen and
Topal, 1983; Eadei et al., 1984).
2.3.2. The repair of MNNG-induced DNA lesions
Damage induced by DNA methylation in living cells is repaired by two major
pathways: direct transfer of the modifying methyl group to the repair protein; and/or
removal of the modified base by a glycosylase, leaving an AP site which is then repaired by
an excision repair process (Friedberg et al., 1995). Nucleotide excision repair, which is
usually involved in repairing adducts that distort the DNA helix, has recently been shown
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to be the third pathway playing a backup role in repairing lesions normally repaired by
alkyltransferases or glycosylases.
The major pathway for repairing 0 6-meG in both prokaryotic and eukaryotic cells
involves the transfer of the methyl group from the DNA to a cysteine acceptor site in the
0 6-methylguanine-DNA methyltransferase (MGMT) (Pegg and Byers, 1992). MGMT
brings about this transfer without the need for any cofactor. The DNA is restored
completely in a single step, but the cysteine receptor site in the protein is not regenerated.
The alkylated form of the protein is unstable in mammalian cells and is degraded rapidly.
The presence of MGMT allows for the rapid repair of 0 6 -meG following exposure to
MNNG as long as the pool of MGMT is not depleted. If the number of 0 6-meG molecules
formed in DNA exceeds the content of MGMT, further repair would require either de novo
synthesis of additional MGMT or the activation of other pathways (Pegg and Byers, 1992).
MGMT is not specific for methyl groups. It is also able to remove larger adducts from the
06 position of DNA, although the rate of such a reaction goes down as the size of the alkyl
group increases (Samson et al., 1988).
The amino acid sequences of MGMT have been determined for a variety of species
including bacteria, yeast, rodent and human. There is a considerable degree of homology
among all of these MGMT sequences (Lindahl et al., 1988; Demple, 1990; Margison et al.,
1990; Morohoshi et al., 1990; Tano et al., 1990; Rydberg et al., 1990; Potter et al., 1991;
Hakura et al., 1991). Both E. coli and Bacillus subtilis contain a constitutive MGMT (Ogt
and Dat, respectively) and an inducible MGMT (Ada and Ada B, respectively). In
eukaryotes, only one MGMT has been detected. The level of the MGMT expression was
found to be inducible (three to five-fold more) by MNNG treatment in rat but not human
cells (Fritz et al., 1991). The human MGMT has 207 amino acids and its gene is localized
on chromosome 10 (Tano et al., 1990; Rydberg et al., 1990). There are striking organ and
species differences in the quantities of MGMT found in mammals (Pegg, 1990). In
general, human tissues and cells have much higher quantities than their equivalent tissues in
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rodents. The liver and spleen have the highest activities of the protein, while the nervous
system and mammary gland have the lowest. There are also significant differences in
MGMT levels among different cell types within any one particular organ. For example, the
level of MGMT is found to be much higher in hepatocytes than in nonparenchymal cells of
the liver (Pegg and Byers, 1992). Such differences may be of importance to a cell's
sensitivity to carcinogenesis or killing by alkylating agents.
Work with the two forms of MGMT (Ogt and Ada) found in E. coli indicates that
both of them are able to repair 0 4 -meT (Lindahl et al., 1988; Demple, 1990). However,
there have been conflicting reports as to the potential of mammalian MGMT to repair 04-
meT. In vitro experiments have demonstrated that purified preparations of human and
rodent MGMT can accept a methyl group from 0 4 -meT (Zak et al., 1994; Kawate et al.,
1995). But the mammalian MGMT does not seem to repair this lesion in vivo (Brent et al.,
1988; Pegg, 1990). Although there are some observations suggesting that 0 4-meT may be
lost from cellular DNA at a relatively slow rate, the enzymatic basis for this reaction has not
been established (Wani et al., 1990; Boucheron et al., 1987).
It has been shown that the excinuclease in the nucleotide excision repair pathway
can act on 0 6-meG in vitro and in vivo (Voigt et al., 1989; Samson et al., 1988; Rossi et
al., 1989). Although the repair efficiency is relatively poor (Van Houten and Sancar,
1987), it has been suggested that excision repair may provide the main protection against
the mutagenicity and toxicity of methylating compounds under conditions in which both the
constitutive and inducible MGMTs are saturated (Samson et al., 1988; Rossi et al., 1989).
The susceptibility to repair by the E. coli uvrABC excinuclease has been shown to increase
with increasing alkyl chain length (Todd and Schendel, 1983; Samson et al., 1988). One
study with human cell lines showed that the cells' capacity for nucleotide excision repair
did not affect either the degree of cell killing nor the mutant frequency induced by MNNG.
However there was an inverse correlation between them when the cells were treated with
ethylnitrosourea (ENU) (Maher et al., 1990). These results indicate that in human cells
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nucleotide excision repair is able to repair 0 6-ethylG, but not 0 6 -meG.
The major pathway for repairing N-methylpurines is base excision repair. In this
pathway, DNA glycosylases catalyze the hydrolytic cleavage of the N-glycosylic bond
linking an abnormal or damaged base to deoxyribose in the sugar-phosphate DNA
backbone, which upon hydrolysis produces an AP site in DNA (Friedberg et al., 1995).
The non-instructive AP sites are then repaired starting with the cleavage of phosphodiester
bonds at the 5' or 3' position on the AP sites by AP endonucleases or lyases, respectively
(Bailly and Verly, 1988). After incision at the AP sites, excision of the damaged sites by
exonucleases and resynthesis of the gapped region then follows (Friedberg et al., 1995).
Several N-alkylpurine-specific glycosylases have been identified. E. coli expresses
one constitutive and one alkylation-induced N-methylpurine DNA glycosylase (MPG)
(Lindahl et al, 1988; Shevell et al., 1990). The constitutively expressed Tag glycosylase
has a narrow substrate specificity, excising only N3-meA from alkylated DNA. The
alkylation-inducible AlkA glycosylase has a somewhat broader substrate specificity,
efficiently excising N3-meA, N3-meG, 0 2-meC and 0 2-meT while inefficiently excising
N7-methylpurine from alkylated DNA. E. coli also possesses a Fapy-DNA glycosylase
enzyme, which exhibits a broad substrate specificity for a variety of lesions having ring-
opened purines including the imidazole ring-opened form of N7-meG (Laval et al., 1990).
cDNAs encoding for the N-methylpurine-DNA glycosylase genes from yeast, rat and
human have also been isolated (Chen et al., 1989; Berdal et al, 1990; O'Connor and Laval,
1990; Samson et al., 1991). The mammalian proteins share a significant homology, but are
quite different from the two E. coli MPGs and the yeast enzyme (MAG protein). The
human N-methylpurine glycosylase gene (MAP) is located on chromosome 16 and
comprises five exons. The purified MAP is able to catalyze the excision of N3-meA, N7-
meG and N3-meG from methylated DNA, but is more specific for N3-meA. It is estimated
that there are 1000 to 2000 MAP molecules per cell (Friedberg et al., 1995).
Recently it has been shown that nucleotide excision repair may be involved in
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removing N-methyl DNA adducts in Drosophila (Nivard et al., 1996). After treatment with
the methylating agents (MNU and N-nitrosodimethylamine), the excision-repair-deficient
strains show an increase in the frequency of A/G -> T transversions as compared to the
wild-type strain. Since the induced transversions are presumably caused by N3-meA and
N7-meG adducts, the results suggest that N-methyl DNA adducts may be the targets for
nucleotide excision repair (Nivard et al., 1996).
2.3.3. The mutational specificity of MNNG
The types of mutations induced by MNNG
The spectra of MNNG-induced mutations contain transitions, transversions,
deletions and insertions (Coulondre and Miller, 1977; Reed and Hutchinson, 1987; Burns
et al., 1987; Richardson et al, 1987a, b; Kohalmi and Kunz, 1988; Gordon et al., 1990;
Cariello et al., 1990; Yang et al., 1991; Lukash et al., 1991; Yang et al., 1993; Kat, 1992;
Kat, 1993). Table 5 summarizes the kinds and numbers of MNNG-induced mutations
observed in the lacI gene in bacteria, SUP4-o gene in yeast and hprt gene in human cells
using clone-by-clone analysis (Kohalmi and Kunz, 1988; Gordon et al., 1990; Yang et al.,
1991; Lukash et al., 1991; Yang et al., 1993). The MNNG-induced point mutational
spectra in the human hprt gene have also been determined by en masse selection of tens of
thousands of 6TG resistant mutants coupled with the PCR/DGGE (or CDCE) approach
(Cariello et al., 1990; Kat, 1992; Kat et al., 1993; Tomita-Mitchell et al., unpublished
results). The obtained mutational spectra in human lymphoblastoid B-cell lines TK6 and
MT I are shown in Fig. 7.
As shown in Table 5 and Fig. 7, the mutations induced by MNNG in these studies
are dominated by single base-pair substitutions, particularly GC -> AT transitions. Despite
the fact that 0 6-meG is only a minor methylation product, the preponderance of transition at
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Table 5. MNNG-induced mutations observed in E. coli lacI gene, Saccharomyces
cerevisiae SUP4-o gene, and human fibroblast hprt gene.
Number of mutations (% of the total)
E. coli S. cerevisiae Human fibroblasts
(lacI)a (SUP4-0)b (hprt)c
Substitutions
Transitions
GC -> AT 619 (97.9) 160 (96.4) 79 (56)
AT ->GC 10(1.6) 2(1.2) 21(15)
Transversions
GC ->CG 2(0.3) 2(1.2) 4(2.9)
GC ->TA 0 2(1.2) 17(12)
AT ->TA 1 (0.2) 0 13 (9.3)
AT ->CG 0 0 6(4.3)
Total 633(100) 166(100) 140(100)
Other mutations
Frameshift (-1) 1 0 1
Deletion 0 0 28d
Insertion 0 0 1
Complex 0 0 13
(a) Data from Gordon et al., 1990.
(b) Data from Kohalmi and Kunz, 1988.
(c) Data from Yang et al., 1991; Lukash et al., 1991; Yang et al., 1993.
(d) Contains putative splice site mutations
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Figure 7. Comparison of spontaneous and MNNG-induced point mutational spectra in the
hprt gene in human lymphoblastoid B-cell lines TK6 and MT 1.
The mutational spectra were obtained through en masse selection of 6TG resistant mutants
and PCR/DGGE (or CDCE) analysis. The total mutant fraction of the hprt gene in the
spontaneous MT1, spontaneous TK6, MNNG-treated MT1 (4 [tM of MNNG, 2x) and
MNNG-treated TK6 (0.04 gM of MNNG) cultures is 3.3 x 10-5, 1.2 x 10-5, 2.7 x 10-2
and 2.5 x 10-5, respectively. The horizontal axis represents the human hprt gene with
scanned exon and intron regions indicated. The size of each vertical bar represents the
frequency of each mutational hotspot relative to the total mutant fraction (MF). The kind of
mutation at the corresponding hotspot is shown. "*" indicates a CpG site. "?" indicates
unidentified sequences.
(Kindly provided by Aoy Tomita-Mitchell)
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GC basepairs is certainly consistent with the predicted significance of its miscoding
potential (Loveless, 1969; Loechler et al., 1984). Among the minor types of MNNG-
induced mutations, AT -> GC transitions are believed to stem from 0 4 -meT lesions
(Preston et al., 1986; Richardson et al., 1987b). The AT/GC -> TA transversions may be
explained by the preferential insertion of adenine through polymerase translesion bypass at
abasic or damaged purine sites (Kunkel, 1984; Loeb and Preston, 1986; Hevroni and
Livneh, 1988). Other transversions may reflect the use of residues other than adenine
during bypass, which may vary from site to site (Randall et al., 1987). Most frameshifts
recovered in lacI following alkylating treatment consist of the loss of one GC basepair from
a contiguous run of GC basepairs (Gordon et al., 1990; Zielenska et al., 1989).
Preferential alkylation of N7-guanine has been found to occur within runs of contiguous
guanine residues by nitrogen mustards, which correlates with the increased electrostatic
potential of these sites (Mattes et al., 1986). It has been postulated that the alkylation
damage may promote the formation of stable extrahelical intermediates resulting in template
misalignments (Horsfall et al., 1990).
It has been shown that the types and frequencies of mutations induced by MNNG
may change depending on the treatment conditions and the cellular background. One study
using diploid human fibroblasts showed that at high doses of MNNG, the mutational
spectrum of the hprt gene was dominated by GC -> AT transition, whereas at low doses
the AT -> GC transition was dominating (Yang et al., 1991). There has been speculation
that at low doses, the 0 6-meG adducts can be very efficiently removed by the MGMT
making 0 4 -meT the major type of premutagenic lesion, while at high doses, the protein is
saturated and 0 6-meG becomes dominant (Yang et al., 1991). Another study, however,
showed somewhat contradictory results that the level of the MGMT activity did not seem to
effect the kinds of mutations induced by MNNG in the hprt gene of human diploid
fibroblasts (Lukash et al., 1991). An imbalanced intracellular dNTP pool may also effect
the types of mutations induced by MNNG. An increased intracellular dCTP:dTTP ratio in
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the yeast S. cerevisiae was found to reduce the frequency of GC -> AT transition but
increased that of GC -> CG transversion in the SUP4-o gene by MNNG (Khalmi et al.,
1993). It was postulated that the reduction in GC -> AT transition was due to dCTP out
competing dTTP for incorporation opposite 0 6 -meG, while the increase in GC -> CG
transversion was due to the increase in the dCTP pool causing error-prone repair of AP
sites resulted from N7-meG (Khalmi et al., 1993; Kunz et al., 1998).
The site specificity of MNNG-induced transition
The distribution of GC -> AT transitions induced by MNNG in a target sequence is
not random. It has been observed that the transitions predominantly occur at guanines
preceded by a purine residue (i.e. at 5'-RG-3' sites) in bacteria, yeast and human systems
(Burns et al., 1987; Richardson et al., 1987a, b; Reed and Hutchinson, 1987; Kohalmi and
Kunz, 1988; Gordon et al., 1990; Yang et al., 1991; Lukash et al., 1991; Kat, 1992).
Some studies report that among all of the available 5'-RG-3' sites, there is a preference for
5'-GG-3' sites over 5'-AG-3' sites (Richardson et al., 1987a; Reed and Hutchinson,
1987). But other studies show that both flanking guanines and adenines equally affect the
distribution of mutation (Burns et al, 1987; Kohalmi and Kunz, 1988; Gordon et al.,
1990). The same 5'-flanking base effect has also been found to influence the distribution of
AT -> GC transitions (Horsfall et al., 1990).
Based on the premise that GC -> AT and AT -> GC transitions are the direct result
of 0 6 -meG and 0 4-meT adducts, several mechanisms have been proposed to explain the
observed influence of the 5' flanking base (Burns et al., 1987). The 5' flanking base may
influence the mutability of a given guanine by effecting: (1) the distribution of 0 6-meG and
0 4 -meT lesions; (2) the efficiency of repair of these lesions; and (3) the fidelity of DNA
polymerase bypassing these lesions.
There is evidence to support the notion that the initial deposition of DNA damage is
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responsible for the observed site specificity. In vitro studies of DNA methylation by MNU
show that the frequency of 0 6 -guanine methylation depends on the nature of the
nucleotides flanking the guanine residue, with a 5' flanking guanine (followed by 5'
adenine) providing the most "permissive" condition and a 5' flanking thymine (followed by
cytosine) the strongest inhibition (Dolan et al., 1988; Sendowski and Rajewsky, 1991). It
has been postulated that the molecular electrostatic potential, an important component of
reactivity, of the 06 position of guanine can be influenced by the adjacent basepairs
(Pullman and Pullman, 1981). By quantum analysis, 0 6-guanine exhibits a greater
potential and accessibility when preceded by a purine than a pyrimidine (Pullman and
Pullman, 1981). However, by comparing the extent of 0 6-meG formation in vitro and the
mutation frequency in vivo at four specific target sites, it was found that the degree of 06_
meG formation influenced but did not completely account for the distribution of mutagenic
hotspots (Richardson et al., 1989).
The MGMT repair can significantly reduce the mutant frequency induced by
MNNG (Lukash et al., 1991), and there is some evidence to suggest that this repair
mechanism can be influenced by sequence context (Topal et al., 1986). However, the 5'-
RG-3' bias has been observed to be independent of the MGMT activity (Richardson et al.,
1987a; Kohalmi and Kunz, 1988; Kat, 1992; Schendel and Robins, 1978; Rossi et al.,
1989). Therefore, the reparability by MGMT is unlikely to be an important factor in the
observed site specificity. The efficiency of nucleotide excision repair of 0 6-meG may also
vary from site to site (Jones et al., 1987). In addition, the excinuclease enzyme seems to
be able to protect some 0 6-meG lesions from MGMT repair through competitive binding of
the lesions and possibly in a sequence-influenced manner (Rossi et al., 1989). One study
showed, however, that the 5'-RG-3' site biases of N-ethyl-N-nitrosourea (ENU)-induced
transition were independent of the excision repair mechanism (Burns et al., 1988).
Finally, the neighboring base may influence the fidelity of the replication process.
Base-stacking interactions at the primer terminus may affect the stability of mispairs, and
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subsequently proofreading and processivity of the DNA polymerase (Kunkel et al., 1981).
Experimental evidence supporting this mechanism in MNNG mutagenesis has yet to be
found.
Several studies including those involving the endogenous hprt gene in human cells
have reported a strand preference in favor of GC -> AT transitions at guanines on the
nontranscribed strand (Richardson et al., 1987a; Reed and Hutchinson, 1987; Yang et al.,
1991; Lukash et al., 1991; Kat, 1992). But this strand specificity has not been found in
other targets (Kohalmi and Kunz, 1988; Gordon et al., 1990). It has been demonstrated
that the observed strand bias is independent of both the MGMT activity and the direction of
replication (Richardson et al., 1987a; Reed and Hutchinson, 1987; Ito et al., 1994).
Using an assay for forward mutations in the rpsL gene in E. coli, it was shown that
upon very active transcription, MNNG induced GC -> AT transitions at guanine residues
on the transcribed strand and that the 5'-flanking base of the sites was predominantly
thymine; upon decreasing the level of transcription, mutations on the non-transcribed strand
were found sharply increased while the 5'-flanking base became predominantly guanine
(Ito et al., 1994). Based on the results, it was suggested that the distribution of 0 6-meG
might be affected by both the level of transcription and transcription-coupled excision repair
(Ito et al., 1994). In contrast to these observations, the transcription level did not seem to
affect the strand bias of MNU-induced mutations observed in a gene cloned in shuttle
plamids in human cells (Palombo et al., 1992). However, the target sequence used in this
study was an extrachromosomal element, which can not represent endogenous nuclear
genes that can be accessed by the DNA repair systems.
To account for the discrepancy in the strand bias of MNNG-induced mutations
among the various targets, Gordon and Glickman (1988) argued that the non-random
distribution of MNNG-induced mutation in some of the targets could be a reflection of the
influence of the mutation on protein structure/function. For example, GC -> AT transition
in the Gly (5'-GGN-3') and Trp (5'-UGG-3') codon sequences are more likely to be
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recovered as a hotspot because Gly residues are often strategic to protein structure and the
transition in Trp coding sequence results in translation termination signals. In fact, under
non-selective conditions, a GC -> AT mutant, which was not recovered by the phenotypic
selection method due to its retained wild-type phenotype, was detected in the lacI gene in E.
coli after treatment with MNNG (Gordon et al., 1990b).
In summary, the observed specificity of MNNG-induced mutational spectra in
selectable genes reflects not only the nature and mutagenic consequence of the induced
DNA lesions, but also the distribution of the lesions, the influence of cellular repair
repertoire and the DNA polymerase fidelity at the lesion sites as well as the effect of
mutation on protein function.
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3. MATERIAL AND METHODS
3.1. Cell culture and MNNG treatment
3.1.1. The human cell lines
Two human B lymphoblastoid cell lines TK6 and MT1 were used in this study.
The TK6 cell line is isolated from the HH4 line which is a derivative of the near diploid
WI-L2 line originally isolated from a male spherocytosis patient (Skopek et al., 1978). Like
its parental lines, TK6 carries one allele of the hprt gene which permits its use as a genetic
marker in in vitro mutation assays using 6TG as the selective agent for mutants. It is also a
heterozygote at the thymidine kinase (tk) locus (on chromosome 17) which provides a
second genetic marker using trifluorothymidine (F3TdR) to select for mutants (Skopek et
al., 1978).
The MT1 line is a clonal derivative of TK6 treated with ICR-191 and then selected
by MNNG (Goldmacher et al., 1986). The phenotypic characteristics of the two cell lines
are compared in Table 6. Both cell lines are deficient in MGMT and exhibit similar
sensitivities to the mutagenic effect of MNNG. However, MT1 is several hundred times
more resistant to the cytotoxicity of MNNG than TK6, and has a spontaneous mutation rate
15 - 30-fold higher than that of TK6 in both the hprt and tk genes (Goldmacher et al.,
1986; Kat et al., 1993).
It has been hypothesized that the distinct phenotypes of MT 1 might be related to a
defect in its strand-specific mismatch repair system (Goldmacher et al., 1986). In vitro
biochemical assays demonstrated that the extract of MT1 cells was indeed deficient in
strand-specific correction of all eight base-base mismatches (Kat et al., 1993). Later it was
found that MT1 cells harbor two missense mutations on separate alleles of the mismatch
repair G/T mismatch-binding protein (GTBP) gene, including an A -> T transversion at
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Table 6. Phenotypic characteristics of TK6 and MT1 cell lines.
Phenotype TK6 MT1
D3 7 (MNNG), 45 min
Spontaneous mutation rate (6TGR)
MNNG-induced mutation (6TGR, 45
min)
Absolute clone-forming ability (low
density, no feeder cells)
Initial survivor doubling time after
MNNG treatment
Initial formation of adducts after 8 kM
MNNG, 45-min treatment
0 6 MeG
3MeG
3MeA
7MeG
7MeA
Half-life of adducts
0 6MeG
3MeG
3MeA
7MeG
7MeA
Initial cell cycle progression effect (one
generation time, lethal dose)
Cell cycle block (three generations)
Hydroxyurea-insensitive [3 H]thymine
uptake into DNA
0.04 gM
1.3 x 10-7 mutations/day
5.7 x 10-4 mutations/cellekM
MNNG
0.36 ± 0.07
18h (unchanged from untreated
cells)
adducts/cell x 10-4
8
24
5
125
3
20 h
19 h
1 h
-17 h
-13 h
No effect after treatment with 0.14
kM MNNG, 45 min
Marked S and G2 + mitosis
accumulation
7-Fold over background (1-h post-
treatment)
6 [tM
5.8 x 10-6 mutations/day
12.5 x 10-4 mutations/cell- M
MNNG
0.014 ± 0.003
36h (increased from 20 h in
untreated cells)
adducts/cell x 10-4
8
24
5
125
3
20 h
17 h
1 h
-17 h
-13h
Marked decrease in S phase fraction
after 10 kM MNNG, 45 min
Return to ~ normal distribution
7-Fold over background (1-h post-
treatment)
(Adapted from Goldmacher et al., 1986)
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codon 1145 and a G -> A transition at codon 1192 (Papadopoulos et al., 1995). Neither of
these mutations are found in TK6 cells (Papadopoulos et al., 1995).
3.1.2. Cell culture and MNNG treatment
Both TK6 and MT1 cells were grown in spinner cultures in RPMI 1640 medium
supplemented with 10% horse serum (Life Technologies, Gaithersburg, MD) in 37'C
humidified incubators with a 5% C02 atmosphere. Cells were maintained in exponential
growth by daily dilution to 4 x 105 cells/ml with the medium. The number of cells was
counted on a model B Coulter counter (Coulter Electronics, Hialeah, Fl). To freeze down
cells, cells were resuspended in fresh medium containing 10% dimethyl sulfoxide (DMSO)
at 5 x 107 cells/ml and stored immediately at -70'C.
Two cultures of 8 x 107 MT1 cells (4 x 105 cells/ml) were independently treated
once with 4 gM MNNG (Sigma Chemical, St. Louis, MO) for 45 min (Kat, 1992). After
treatment, the cells were resuspended in fresh medium and grown for 30 generations with
daily dilution to diminish any induced premutagenic lesions which could be mistaken for
mutations in the procedure. Untreated MT 1 cells grown in parallel served as controls.
3.1.3. Determination of the hprt gene mutant fractions
Mutant fractions of the hprt gene in MT1 cells were measured using a microtiter
plate mutation assay (Furth et al., 1981). Cells were properly diluted with fresh medium
and plated in 96-well microtiter plates in the presence and absence of 6TG. For the
determination of plating efficiency (PE), cells were plated at 2 cells/well in four plates
without 6TG. For the determination of HPRT mutant fraction, cells were plated at 400
cells/well for MNNG-treated MT1 cells or 40,000 cells/well for untreated MT1 cells in
sixteen plates in the presence of 1 pg/ml 6TG. The plates were then kept in 37'C
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humidified incubators with a 5% CO2 atmosphere for 14 - 18 days until visible colonies
formed. The number of wells with no colonies in each plate was counted.
The distribution of colonies among wells is considered a Poisson distribution. The
average number of colony forming units per well (k) can be calculated from P(0) = e-k,
where P(0) is the probability of any well having no colonies, which can be approximated
by the fraction of all wells observed that have no colonies (# wells with no colonies / #
wells scored).
The PE of a culture is defined as X divided by the average number of cells plated
per well in the absence of 6TG:
# wells with no colonies
E- In P(0) - In # wells scoredPE===
# cells per well # cells per well # cells per well
Only 6TG resistant (6TGR) HPRT mutants can form colonies when plated in the
presence of 6TG. The hprt mutant fraction is determined as:
# 6TG wells with no colonies
- In # 6TG wells scored
MF =
# cells per 6TG well x PE
3.2. Isolation of genomic DNA from cultured cells, blood and solid tissues
For cultured cells, the sample was centrifuged at 2500 rpm for 5 min. The
supernatant was discarded and cells were resuspended in 1 x TE buffer (50 mM Tris-HCl,
pH 8.0, 10 mM EDTA) at 106 - 107 cells per ml. For thawed blood, one volume of
phosphate-buffered saline (PBS) solution was added to the sample. The sample was
centrifuged at 6000 g for 15 min. The supernatant was discarded, and the pellet containing
white blood cells was resuspended in PBS and centrifuged again. The procedure was
repeated twice. The pellet was finally resuspended in 1 x TE at ~106 white blood cells
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(equivalent to 1 ml of blood) per ml. For solid tissue biopsy sample, the tissue was cut into
small pieces with a scalpel and deeply frozen in liquid nitrogen. Using a mortar and pestle,
the tissue pieces were homogenized to a fine powder as thoroughly as possible. The
powder was suspended in 1 x TE at 50 mg of tissue per ml.
To the above cell or tissue suspension was then added Proteinase K (20 mg/ml) and
sodium dodecyl sulfate (SDS) (10%) to a final concentration of 1 mg/ml and 0.5%,
respectively. The sample was mixed by vortexing and incubated in a 50'C water-bath
shaker shaking at 200 min-1 for 3 hr. RNaseA (10 mg/ml) was added to the sample at a
final concentration of 0.1 mg/ml. After mixing the sample was incubated in the water-bath
shaker at 37'C shaking at 200 min-1 for 1 hr.
After incubation, the sample was centrifuged at 13,000 rpm at 4'C for 15 min. The
central portion of the supernatant was transferred to a new tube using a Pasteur pipette.
Care was taken to avoid the bottom pellet and the top layers of white matter (sometimes fat)
in tissue samples. The above procedure was repeated two to three times to collect as much
of the supernatant as possible.
To the collected supernatant was added 5 M NaCl to a final concentration of 250
mM and two volumes of 100% ethanol. The sample was mixed gently by inverting the tube
to form the DNA spool. After it became compact and floated on the surface of the
supernatant, the spool was transferred to a new tube and washed twice with cold 70%
ethanol. The DNA was air dried for about 30 min. 0.1 x TE was added to a concentration
of 2 - 4 mg DNA per ml. The sample was then vortexed vigorously until the DNA was
completely dissolved.
The concentration and purity of the isolated genomic DNA was assessed by
absorbance (A) measurements at 260 and 280 nm wavelengths. The concentration of the
DNA sample was calculated as: A2 60 x 50 pg/ml x dilution factor. The ratio of A260/A280
was used as an indicator of DNA purity.
The genomic DNA was digested with endonucleases Hae III and Xba I (New
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England Biolabs, Beverly, MA) at a DNA concentration of 2 - 3 mg/ml and an
enzyme/DNA ratio of 1 U/gg at 37'C overnight.
3.3. Enrichment of the desired DNA fragments from genomic DNA
3.3.1. Size fractionation by polyacrylamide gel electrophoresis (PAGE)
Preparative PAGE gels (17 cm x 16 cm x 1.5 mm) contained 6.4% acrylamide and
1/40 bis-acrylamide in 1 x TBE (89 mM Tris-borate, pH 8.3, 1 mM EDTA). The gels
were polymerized with 0.1% ammonium persulfate and 0.1% N,N,N',N'-
tetramethylethylenediamine (TEMED). Up to 1 mg of genomic DNA digested with Hae III
and Xba I was loaded in the middle preparative lane. About 0.5 pg of pBR322 DNA
digested with Msp I endonuclease was loaded on the two side marker lanes.
Electrophoresis was performed at a constant voltage of 250 V for 1 hr. After
electrophoresis, the two side marker lanes were cut out from the gel and stained in ethidium
bromide solution (2 tg/ml in 1 x TBE) for a few minutes. The pBR322/Msp I marker
bands were visualized under a UV transilluminator. The position corresponding to the size
of the desired genomic DNA fragment was marked by making a notch on the edge of the
gel segments. The marked gel segments were then put back to their original positions in the
PAGE gel. Based on the position of the two notches, the gel slice containing the desired
genomic DNA fragment in the middle lane was cut out.
DNA was electroeluted from the gel slice using a D-gel apparatus (Epigene Corp.,
Baltimore, MD). Briefly, the gel slices were cut into small pieces and put on top of the
electroelution columns pre-packed with DEAE cellulose in 1 x TBE. Electroelution was
performed at 125 V for 2 hr. The columns of DEAE cellulose were then drained completely
of the TBE buffer, and washed twice with 4.5 ml of 0.2 M NaCl. The NaCl solution was
drained, and DNA was eluted from the DEAE cellulose twice with 250 gl of 1 M NaCl.
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The DNA in the eluate was precipitated with two volume of 100% ethanol at -20'C
overnight. The sample was centrifuged at 14,000 rpm for 10 min. The DNA pellet was
washed twice with cold 70% ethanol, air dried and dissolved in 5 pl of ddH20.
3.3.2. Sequence-specific enrichment
To the genomic DNA digested with Hae III and Xba I were added 20 x SSPE and
10% SDS to reach a final concentration of 6 x SSPE (1.08 M NaCl, 60 mM sodium
phosphate, pH 7.4, 6 mM EDTA) and 0.1% SDS, and the two 5'-biotinylated 30-mer
probes BP1 (5'-CAAAACTGACAGCACAGAATCCAGTGGAAC) (APC cDNA bp
8472-8501) and BP2 (5'-AAGACCCAGAATGGCGCTTAGGACTTTGGG)
(complementary to APC cDNA bp 8501-8530) (Synthetic Genetics, San Diego, CA) to a
probe/target molar ratio of 5 x 104. The mixture was dispensed into several 1.5-ml
microcentrifuge tubes (- 0.8 ml / tube), heated in boiling water for 2 min and immediately
chilled in an ice bath for 10 min. The sample tubes were incubated at 58'C for 2 hr.
Streptavidin-coated glass paramagnetic beads (CPG, Lincoln Park, NJ) (0.4 mg
beads per 108 copies of the target fragment) were prewashed twice with the washing buffer
(IM NaCl, 10 mM Tris-HCl pH 7.6, 2 mM EDTA). The beads were then dispensed into
each of the sample tubes and kept suspended in the DNA solution at 50'C for 1 hr using a
temperature-controlled rotary thermomixer (Brinkmann Instruments, Westbury, NY) at
1000 min-1. After incubation, the beads were magnetically collected to the side of the
sample tube by placing a neodymium magnet against the wall of the tube. The solution was
removed and all the beads belonging to the same sample were combined.
The beads were washed four times with the washing buffer. At each time the beads
were resuspended in the washing buffer at 10 mg beads/ml in the rotating thermomixer at
50'C, 1000 min-I for 5 min. DNA was eluted twice by incubating the beads with ddH20 at
20 mg/ml at 70'C for 2 min. The eluate was then concentrated to about 10 pl through
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speed-vac centrifugation. 0.1 volume of 10 x reannealing buffer (2 M NaCl, 100 mM Tris-
HCl, pH 7.6, 20 mM EDTA) was added to the sample. The sample was then reannealed at
55'C for 16 hr.
The reannealed sample was digested with endonucleases Sau3A I and Acc I (New
England Biolabs) in a 100 - 300 gl reaction. The digested sample was desalted and
concentrated through ultrafiltration using Microcon-50 devices (Amicon, Beverly, MA)
(see Section 3.7.2.). The volume of the desalted samples (20 to 50 gl) was further
concentrated to 4 - 10 gl by speed-vac centrifugation.
3.4. High-fidelity PCR
High-fidelity PCR was performed in 10 - 50-pl glass capillary tubes using native
Pyrococcus furiosus (Pfu) DNA polymerase (Stratagene, La Jolla, CA) and an Air
Thermo-Cycler TM (Idaho Technology, Idaho Falls, ID).
The PCR mixture contained 20 mM Tris-HCl (pH 8.0), 2 mM MgCl2, 10 mM
KCl, 6 mM (NH 4 )2SO 4 , 0.1% Triton X-100, 0.1 mg/ml BSA, 0.1 mM dNTPs, 0.2 gM
each primer, and 0.1 U/ l Pfu. The primers used to amplify a 206-bp mitochondrial DNA
(mitochondrial DNA bp 10011-10215) are CW7 (5'-ACCGTTAACTTCCAATTAAC)
(mitochondrial DNA bp 10011-10031) and 5'-fluorescein labeled J3 (5'-GCGGGCGCAG
GGAAAGAGGT) (complementary to mitochondrial DNA bp 10196-10215). The primers
for amplification of a 243-bp APC sequence (APC cDNA bp 8441-8683) were 5'-
fluorescein labeled API (5'-GAATAACAACACAAAGAAGC) (APC cDNA bp 8441-
8460) and AP4H (5'-AACAAAAACCCTCTAACAAG) (complementary to APC cDNA bp
8664-8683). The PCR mixture was siphoned into a glass capillary tube (Idaho
Technology) and the two ends of the tube were then sealed in a flame of a gas burner. The
capillary tube was placed in an air thermocycler.
The reaction conditions were as follows: 94'C for 2 min; appropriate cycles, each
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cycle with -10 sec at 94'C for denaturation, -20 sec at 57'C (for the mitochondrial
sequence) or 50'C (for the APC sequence) for annealing, -20 sec at 72'C for extension;
and 72'C for 2 min. To create mutant/wild-type heteroduplexes, a sufficient number of
PCR cycles was performed in order to deplete most of the primers so that the mutants could
reanneal with excess wild-type DNA during the final cycles. To create homoduplexes,
aliquots of PCR products were subjected to only 3 - 6 cycles of PCR so that excess primers
were still present in the final reactions. After the reaction, the two ends of the capillary tube
was cut open with a glass cutter. The PCR reaction was then transferred into a 0.5-ml
microcentrifuge tube.
Post-PCR incubations were performed to remove interfering PCR byproducts. The
products of the mitochondrial DNA were incubated at 45'C for 30 min and the products of
the APC sequence were incubated with additional Pfu (half of the amount used in the PCR
reaction) at 72'C for 5 min.
3.5. Constant denaturant gel electrophoresis
CDGE gels (17 cm x 16 cm x 0.4 mm) contained 7.5% acrylamide and 1/40 bis-
acrylamide in 1 x TAE (40 mM Tris-acetate, 1 mM EDTA, pH 8.0). The gels were
polymerized with 0.1% ammonium persulfate and 0.1% TEMED. The gels were
submerged in a 1 x TAE buffer tank which was pre-heated to a precise temperature around
70'C. After the samples were loaded, electrophoresis was performed at a constant voltage
of 160 V for 90 min. Extensive circulation of the buffer was provided by a constant
temperature circulator during the runs.
Test runs were performed to determine the optimal separation temperatures using
PCR amplified APC gene wild-type and artificial mutant fragments and fluorescein-labeled
DNA markers which were PCR amplified hprt gene exon 3 wild-type and mutant
homoduplexes and heteroduplexes. After electrophoresis, the gels were stained in ethidium
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bromide solution (2 ig/ml in 1 x TAE) for a few minutes, and photographed using a UV
transilluminator.
Separation of cellular DNA was performed at the determined optimal conditions.
After electrophoresis, the fluorescein-labeled DNA markers were visualized by illuminating
the gel with the 488 nm argon laser. Each marker band was marked on the plate while
viewing the gel through a 520 nm low pass glass filter (Oriel, Stratford, CT). Based on the
results of test runs, the relative positions of the markers provided information on the exact
position to which the desired cellular APC mutants migrated in the gel. The portions of the
gel below and above the wild-type DNA marker band were cut so as to include the range of
mobilities of most mutant fragments.
The gel slices were finely ground between two glass slides and transferred into 1.5
ml microcentrifuge tubes containing 200 ptl of 200 mM NaCl. DNA was eluted from the gel
by shaking for 20 min at 50'C, 1300 min- 1. The tubes were centrifuged at 14,000 rpm for
10 min to spin down gel particles. The supernatant was collected. DNA was then ethanol
precipitated from the supernatant, washed with 70% ethanol and dissolved in 10 pl of
ddH2O.
3.6. Constant denaturant capillary electrophoresis
3.6.1. The CDCE instrument
The diagram of the CDCE apparatus is shown in Fig. 8. Adapted from the CE
instrument for separation of DNA sequencing products (Cohen et al., 1990), the key
element of CDCE is a heated zone of capillary positioned before the detection window
where DNA separation takes place (Khrapko, et al., 1994). The temperature of the heated
zone can be controlled by a surrounding water jacket connected to a constant temperature
circulator.
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Figure 8. Diagram of the CDCE apparatus.
The power supply (PS) is 30 kV DC (Model CZE 100OR-2032, Spellman, Hauppauge,
NY). Laser beam from an argon ion laser (AIL) (Model 5425ASL, Ion Laser Technology,
Salt Lake City, UT) is filtered through a 488 nm narrow band-pass filter (Fl) (10 nm
bandwidth) (Corion, Franklin, MA), reflected by a 450 mirror (M) (Newport, Irvine, CA),
and focused by a plano-convex glass lens (L) (Newport) onto a detection window of a
horizontally positioned fused silica capillary (CAP). Fluorescence emitted from the sample
is collected by a 60 x microscope objective (MO) (Newport) and passed through a 540 nm
and a 530 nm filter (F2) (Corion) into a photomultiplier (PMT) (Oriel Instruments,
Stratford, CT). The signal from the photomultiplier is amplified (107 or 108 V/A) by a
current preamplifier (CPA) (Oriel), recorded by a data acquisition system (DAS) (ACM2-
16-8A/T51B, Strawberry Tree Computers, Sunnyvale, CA), and transmitted to a
Macintosh computer. The buffer reservoirs (BR) are positioned at the two ends of the
capillary. At the cathodic end, the capillary is inserted into a water jacket (WJ) the
temperature of which is controlled by a constant temperature water circulator (WC).
DAPA
OMPUTER
F2
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3.6.2. Coating of capillaries
The inner surfaces of fused silica capillaries (Polymicro Technologies, Phoenix,
AZ) were coated with 6% linear polyacrylamide via siloxane bonding to prevent
electroosmotic flow (Hjerten, 1985). The capillary was treated with 1 M NaOH for 1 hr,
washed with dd H20 and filled with 1 M HCl for 10 min. The capillary was then washed
with 100% methanol, and treated with y-methacryloxypropyltrimethoxysilane (Sigma, St
Louis, MO) overnight. After being washed with 100% methanol, the capillary was filled
with a polymerizing solution consisting of 6% acrylamide in 1 x TBE, 0.1% TEMED and
0.025% ammonium persulfate. The capillary was left overnight before use.
3.6.3. Preparation of linear polyacrylamide matrices
The linear polyacrylamide matrix used in CDCE was prepared in large quantities
and stored at 0 - 4'C (Ruiz-Martinez, et al., 1993; Hanekamp, et al., 1996). The matrix
was dispensed into 100-+1 high pressure syringes to be injected into capillaries before each
run. The matrix was prepared as follows.
In a 250-ml flask, 150 ml of 5% acrylamide solution was prepared in 1 x TBE. 45
gl of TEMED was then added. The flask was placed in an ice bath on a stir plate and the
solution was stirred by a stir bar. The top of the flask was covered with at least 10 layers
of Parafilm. Two small holes were punched through the Parafilm with a needle. A long
stainless steel needle was inserted into the solution through one of the holes. The needle
was connected to an argon cylinder with silicone tubing. Argon gas was then drawn into
the acrylamide solution and kept bubbling for 1 hr to deoxygenate the solution.
The tip of the long needle was lifted above the surface of the solution to stop
bubbling but maintain the argon pressure in the flask. 45 tl of 10% ammonium persulfate
was then added into the solution using a 100-+1 high pressure syringe. The polymerizing
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solution was immediately dispensed into several pre-chilled 10 - 50 ml glass syringes. To
fill a syringe, a pipetting needle was attached to the syringe and inserted into the flask. The
syringe was rinsed twice with argon gas inside the flask and once with small amounts of
the polymerizing acrylamide solution. The syringe was then filled with the solution. The
pipetting needle on the syringe was replaced with a thin stainless steel needle. The end of
the needle was sealed by inserting it into the wall of a short piece of silicone tubing. The
syringe was placed in vertical position (needle tip down) at 0 - 4'C while the matrix
polymerized.
3.6.4. CDCE conditions, sample loading and fraction collection
Coated capillaries were cut 20 to 33 cm in length with the detection window opened
7 cm from the capillary outlet (the anodic end). DNA samples were introduced into each
capillary electrokinetically. Separations of mutant/wild-type heteroduplexes from wild-type
sequences in the target-enriched cellular DNA were performed in a 20 cm long, 540 pm
i.d. capillary inserted into a 6 cm water jacket at - 66'C. The desalted sample (about 4 gl)
was injected into a short piece (about 1 cm) of Teflon tubing and tightly mounted onto the
capillary inlet. The capillary inlet with attached tubing was then inserted into the inlet buffer
reservoir and an electric current was applied at 80 pA for 2 minutes. This process achieved
complete loading of the injected sample. The tubing was removed after sample injection,
and the capillary inlet was inserted back into the buffer reservoir. Electrophoresis was
performed at a constant current of 80 gA. The desired fractions were electro-eluted into 10
jil of 0.8 x TBEB (0.8 x TBE, 0.24 mg/ml) for 10 to 20 min per fraction. The collected
fractions were desalted through drop dialysis (see Section 3.6.5) and concentrated before
being reloaded onto the capillary for a second separation.
Separations of PCR products were performed in 75 gm i.d. capillaries. 0.5 p1 of
product solution was diluted to 5 p1 with water to reduce the ionic strength of the loading
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solution. The inlet buffer reservoir was replaced by the sample vial and an electric field was
applied at 2 [tA for 30 sec to 2 min. After injection, the capillary inlet was inserted back
into the buffer reservoir and electrophoresis was performed. For separation of
heteroduplexes from the wild-type homoduplex, CDCE was performed at a constant
current of 9 jiA in a 21-cm capillary inserted into a 6-cm water-jacket at 64.6'C. The
desired heteroduplex fraction was collected into 10 p1 of 0.1 x TBEB for about 3 min. For
separation of the wild-type and mutant homoduplexes, CDCE was performed at 8 pA in a
33 cm capillary inserted into a 19 cm water jacket at -65.2'C. The linear polyacrylamide
inside the capillary was replaced for each run.
3.6.5. Methods for desalting DNA samples for CE separation
Drop dialysis
Drop dialysis is a simple and rapid method for dialysis of small-volume samples (<
50 pl) with a high recovery (Marusyk and Sergeant, 1980). A membrane filter of pore size
0.05 gm in diameter (Millipore, Bedford, MA) was floated on the surface of dialysis buffer
containing 0.01 - 0.1 x TBE in a small shallow container (such as a plastic weight boat)
placed on a stir plate. A 5 to 50-gl drop of the sample was carefully pipetted on the floating
membrane filter. The sample was dialyzed for 1 to 3 hr while the dialysis buffer was
slowly stirred by a small stir bar. After dialysis, the droplet was recovered from the
membrane with a micropipet.
Ultrafiltration
Ultrafiltration utilizes centrifugation to force liquid and small molecules (salts,
nucleotides, DNA oligo primers, etc.) through a low-binding membrane with an
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appropriate molecular weight cut-off. Solutes larger than the nominal cut-off (such as
protein and DNA) are retained on top of the membrane. Through repeated centrifugation
followed by reconstitution with water, ultrafiltration can be used to efficiently concentrate
and desalt samples. In this study, a disposable ultrafiltration device, Microcon-50 (50,000
Dalton MW cut-off) (Millipore) was used to desalt and concentrate 100 - 500 p1 of
restriction digested DNA samples. This method was also used to desalt and remove
residual primers from PCR amplified DNA fragments (20 - 50 pl) for sequencing.
The protocol was as follows. ddH20 was added to the sample to a total volume of
500 p1. The sample was then pipetted into a Microcon sample reservoir inserted into a vial.
The assembly was centrifuged at 14,000 x g for 6 - 7 min. The eluate in the vial was
discarded. 400 - 490 p1 of ddH20 was added to the sample reservoir, and the assembly
was centrifuged once more at 14,000 x g for 6 - 7 min. This process (called diafiltration)
was usually repeated again for desalting restriction digested DNA samples. The sample
reservoir was then placed upside down in a new vial, and spun 3 min at 1000 x g to
transfer the sample (20 - 40 gl) into the vial. If the sample was genomic DNA, it was
further concentrated to 4 - 10 p1 through speed-vac centrifugation.
3.7. The choice of the APC gene target sequence
Single-copy nuclear gene fragments suitable for this study should (1) contain two
contiguous isomelting domains differing by at least 50C, a feature permitting their facile
analysis by CDCE; and (2) be flanked by endonuclease recognition sites which are not
found within the fragments, a feature allowing their release from genomic DNA. As an
initial sequence for developmental work, a 271-bp human APC gene fragment (APC cDNA
bp 8434-8704) was chosen for this study. This fragment is composed of a high and low
melting domain with a temperature differential of 1 VC (Fig. 9). It can be excised from
human genomic DNA by endonucleases Sau3A I and Acc I which recognizes APC cDNA
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Figure 9. Melting map of the APC gene cDNA bp 8434-8704 fragment.
The melting temperature was calculated according to the melting algorithm of Lerman and
Silverstein (1987). The positions of the recognition sites of endonucleases Sau3A I and
Acc I are indicated by arrows. The positions of the primers (AP1 and AP4H) used in high-
fidelity PCR to amplify this fragment are indicated by bars.
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bp 8430-8433 and 8703-8708, respectively. The target sequence where point mutations
can be detected comprises 121 base pairs (APC cDNA bp 8543-8663) within the low
melting domain of the chosen fragment (see Section 4.1).
The human APC gene is localized on chromosome 5q21-22. It contains fifteen
exons and an 8538-bp open reading frame (Groden et al., 1991). The chosen 121-bp APC
target sequence is located in exon 15. It is transcribed but not translated in vivo. Although
APC gene mutations have been found in the majority of colorectal cancers as well as in
dysplasia of colon mucosa (Nagase and Nakamura, 1993; Powell et al., 1992), no
mutation in this particular 121-bp sequence has been reported.
3.8. Construction of artificial mutants
To evaluate the CDCE behavior of the chosen APC gene fragment, two artificial
point mutants were created through PCR amplification of TK6 genomic DNA with the
fluorescein-labeled high melting domain primer API (APC cDNA bp 8441-8460) and two
low melting domain primers (PmutL and PmutH) each containing a mismatched base with
the wild-type sequence. The two artificial mutants, mutL and mutH, were designed to
carry a G:C -> A:T and an A:T -> G:C transition at APC cDNA bp 8660 and 8652,
respectively. The sequences of the two low melting domain primers are as follows:
PmutL (complementary to APC cDNA bp 8656-8700):
5'-TCAAATATGGCTTCCAGAACAAAAACCCTCTAACAAGAATrAAAC
where the underlined T forms a G:T mismatch at bp 8660 with the wild-type sequence;
PmutH (complementary to APC cDNA bp 8648-8683),
5'-AACAAAAACCCTCTAACAAGAATCAAACCTACTTAC,
where the underlined C forms a A:C mismatch at bp 8562 with the wild-type sequence.
A 492-bp artificial mutant (APC cDNA bp 8422-8913) carrying an AT -> GC
transition at APC cDNA bp 8652 was created to be used as an internal standard mutant
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compatible with the 482-bp APC gene fragment digested from genomic DNA by Hae III
and Xba I (see Section 4.2). To construct this mutant, a 262-bp APC fragment (APC
cDNA bp 8422-8683) containing an AT -> GC transition at bp 8652 was first produced by
PCR amplification of TK6 genomic DNA. The PCR primers were interior fluorescein-
labeled primer ISI (5'-CCATCTCAGATCCCAACTCC) (APC cDNA bp 8422-8441; the
Sau3A I recognition site underlined and the fluorescein-labeled thymine residue in bold)
and primer PmutH containing the desired A:C mismatch with the wild-type DNA. Also, a
492-bp wild-type APC fragment was PCR amplified using primers ISI and IS2 (5'-
TATAATCTAGAAATGATTGA) (complementary to APC cDNA bp 8894-8913). The
262-bp mutant fragments were then mixed in a large excess with the 492-bp wild-type
fragments. The mixture was amplified using ISI and IS2 to produce the 492-bp mutant
internal standard.
3.9. Measurement of the copy number of the target sequence and the
efficiency of restriction digestion
To measure the target copy number in a DNA sample, a small aliquot of the sample
was mixed with known copies (Nm) of the artificial mutant and subjected to PCR using
primers API and AP4H. The PCR products were then separated by CDCE. The initial
target copy number (Nt) in the sample was calculated based on measurement of the area
under the wild-type (Aw), mutant (Am) and the average of the two heteroduplex (Ah) peaks:
Nt = Nm * (Aw + Ah) / (Am+ Ah).
The internal standard mutant was also used to measure the efficiency of the Sau 3AI
and Acc I digestion that release the desired 271-bp APC gene fragment from genomic
DNA. Poor digestion efficiency could occur as a result of incomplete DNA reannealing or
enzyme dysfunction due to the amounts of salts and EDTA carried over from the previous
target enrichment procedures (see Section 4.4). It was therefore necessary to check
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whether the digestion was complete (over 90%) before proceeding to the subsequent steps
for enriching the mutant sequences.
Fig. 10 illustrates the method designed to quantitatively measure the Sau 3A I and
Acc I digestion efficiency. A small aliquot of the Sau3A I/Acc I digested sample was mixed
with known copies of the internal standard mutant. One half of the mixture was subjected
to PCR using primers API and AP4H by which the mutant internal standard and both the
digested and undigested target fragments could be amplified. The PCR products were
separated by CDCE and the total target copy number (Nt) in the digestion was measured.
The other half of the mixture was amplified using primers IS1 and BP4 (5'-
GGTGCTACTTTAAATACATG) (APC cDNA bp 8787-8796) by which only the
undigested target fragments and the mutant internal standard could be amplified. The copy
number (Nu) of the undigested target fragments was determined by amplifying a small
aliquot of the 375-bp PCR products using primers API and AP4H followed by CDCE
separation. The Sau3A I/Acc I digestion efficiency was calculated as (Nt - Nu) / Nt.
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Figure 10. Quantitative measurement of the Sau3A I and Acc I digestion efficiency.
See text for details.
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4. RESULTS AND DISCUSSION
4.1. Optimization of the CDCE/high-fidelity PCR conditions
Optimization of the PCR conditions for the chosen 271-bpAPC gene fragment
(APC cDNA bp 8434-8704) involved three steps: (1) a suitable position of the low melting
domain primer was determined to facilitate CDCE analysis of the amplified fragments; (2)
appropriate PCR cycling conditions were determined to obtain an optimal amplification
efficiency; and (3) a post-PCR incubation procedure was devised to remove interfering
PCR byproducts.
The size of the low melting domain was found to be a critical factor in determining
the separation efficiency of the amplified APC gene fragments by CDCE. Initially, the
position of the low melting domain primer was chosen to be complementary to APC cDNA
bp 8681-8700 (AP2). Amplification of human genomic DNA using primers API and AP2
produced a 260-bp APC gene fragment containing a 157-bp low melting domain. When
subjected to CDCE, this fragment appeared as a very broad peak, and the resolution of the
wild-type and mutL peaks was poor. Although it was found that the CDCE resolution
could be improved by lowering the running current (2 gA instead of 9 jiA) or using longer
water-jacket (28 cm instead of 6 cm), the extended separation time ( 1- 2 hr instead of 25
min) at these conditions was prohibitive for routine operations. A new primer AP4H
(complementary to APC cDNA bp 8654-8683) was then designed so that the size of the
low melting domain of the amplified APC gene fragment was shortened by 16 basepairs.
The resultant 243-bp PCR fragments had a 141-bp low melting domain including a 121-bp
measurable target size (APC cDNA bp 8543-8663). It was found that the reduction in the
size of low melting domain greatly increased the separation efficiency of the amplified
fragment.
These experimental results are consistent with the notion that peak broadening on
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CDCE is caused by an interconversion between the migration states of DNA molecules (i.e.
the partially melted and unmelted states) with different electrophoretic mobilities (Khrapko
et al., 1996). According to a random walk model (Khrapko et al., 1996), the peak variance
(a) is given by: y = 1(n) 1/2, where / is the length of an elementary step and n is the number
of steps taken. In CDCE separation, I is proportional to AtE, where At is the life time of
one of the two migration states and E is the electric field strength; and n is proportional to L
/ AtE, where L is the migration distance (i.e. the length of the water-jacket). Therefore, the
peak variance on CDCE is proportional to (AtEL) 1/2 (Khrapko et al., 1996). According to
this model, a high efficiency separation (small cy) on CDCE can be achieved by reducing
the field strength (E), the length of the water-jacket (L) and the life time of one of the two
migration states (At). Since At is proportional to the length of the low melting domain of
the DNA molecule, a reduction in the low melting domain will lead to an increase in the
separation efficiency.
The use of primer AP4H in amplifying the chosen APC gene fragment, however,
introduced several interfering PCR byproducts which migrated slower than the desired
fragment on CDCE (Fig. 11 A and B). The single-stranded forms of these byproducts
appeared to be shorter than the normal fragment by one to four nucleotides upon CE
separation. Interestingly, these byproducts were not produced by exo- Pfu (without the
exonuclease activity) or Taq polymerase, indicating that they were associated with the
exonuclease activity of the native Pfu. Several attempts were made to eliminate these
byproducts. It was found that their level in the final PCR products were not effected by
changing the concentrations of dNTP or PCR buffer components, but could be reduced
(but not eliminated) by increasing the amounts of native Pfu polymerase used in PCR.
Finally, it was discovered that these byproducts could be removed by incubating the final
PCR reaction with additional thermostable DNA polymerase (including native and exo-
Pfu, Taq and Vent) at 72'C for 5 - 10 min (Fig. 1 C).
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Figure 11. Removal of interfering PCR byproducts by a post-PCR incubation procedure.
About 0.1 g of TK6 genomic DNA was subjected to PCR amplification using primers
API and AP4H in 10-gl reaction for 42 cycles. CE was performed at 9 gA in a 26 cm, 75
gm i.d. capillary with the detection window positioned at 7 cm from the capillary outlet.
The horizontal axis represents the time since starting the run, and the vertical axis
represents the relative intensity of fluorescence. A, CE separation of the PCR products at
room temperature. B, CDCE separation of the PCR products at 64.2'C using a 6-cm water-
jacket. C, CDCE separation of the PCR products which had been incubated with additional
0.5 unit of Pfu at 72'C for 10 min.
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Optimal PCR cycle conditions were determined based on measurement of the PCR
efficiency. The PCR efficiency per cycle during the exponential phase of PCR was
calculated according to the equation: Np = Nt (1 + e)n, where to Nt and Np are the target
copy number of the template and product, respectively, n is the number of cycles and e is
the efficiency per cycle during the exponential phase of PCR. At the optimal PCR cycle
conditions (described in Section 3.4.), the efficiency was estimated to be 50 - 60%.
To determine a suitable temperature range for CDCE separation of the 243-bp APC
gene fragments (APC cDNA bp 8441-8683), PCR amplified wild-type and artificial mutant
mixtures containing two homoduplexes and two heteroduplexes were subjected to CDCE at
various temperatures. The two artificial mutants, mutL and mutH, were designed to carry a
G:C -> A:T and an A:T -> G:C transition at APC cDNA bp 8660 and 8652, respectively.
As shown in Fig. 12 and 13, the wild-type homoduplex can be well separated from both
the low and high Tm mutants as well as the heteroduplexes at appropriate temperatures. It
should be noted that the optimal separation temperatures may be slightly different for
different batches of 5% linear polyacrylamide matrices.
4.2. Processing of large quantities of genomic DNA from human cells and
tissues
4.2.1. The phenol-free DNA isolation procedure
A modified genomic DNA isolation procedure was developed without the use of
phenol, a compound which may potentially cause DNA damage. In this procedure,
genomic DNA was isolated from the cells or tissues through digestion with proteinase K (1
mg/ml), SDS (0.5%), and RNaseA (0.1 mg/ml) followed by centrifugation and ethanol
precipitation. The procedure provided a greater than 90% yield (9 mg) of genomic DNA
from 109 cultured cells or 4 grams of tissues. The A260/A280 ratio was determined to be
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Figure 12. Demonstration of CDCE separation of the 243-bp APC gene fragments at
various temperatures (I).
The DNA samples being separated here are PCR amplified 243-bp APC gene fragments
(APC cDNA bp 8441-8683) including the wild-type homoduplex (GC), the mutL
homoduplex (AT), and the two mutant/wild-type heteroduplexes (GT and AC). CDCE was
performed at conditions described in Fig. 11 except that a different batch of polyacrylamide
matrix was used.
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Figure 13. Demonstration of CDCE separation of the 243-bp APC gene fragments at
various temperatures (II).
The DNA samples being separated here are PCR amplified 243-bp APC gene fragments
(APC cDNA bp 8441-8683) including the wild-type homoduplex (AT), the mutH
homoduplex (GC), and the two mutant/wild-type heteroduplexes (GT and AC). CDCE was
performed at conditions described in Fig. 11 except that a different batch of polyacrylamide
matrix was used.
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1.5 - 1.8 and 1.3 - 1.6 for DNA isolated from cultured cells and tissues, respectively. The
genomic DNA isolated through this procedure was readily digested by restriction
endonucleases.
4.2.2. Sequential release of the desired APC gene fragment from human genomic DNA
It was financially prohibitive to use endonucleases Sau3A I and Acc I to excise
directly the 271 -bp APC gene fragment from the large amounts of genomic DNA required
for this study ($2112 for digestion of 10 mg DNA at 1 unit enzyme/gg DNA). To reduce
the monetary cost, a two-step digestion strategy was used (Fig. 14). A 482-bp APC gene
fragment (APC cDNA bp 8422-8903) containing the desired sequence was first excised by
digestion with endonucleases Hae III and Xba I which are 10-fold less expensive than
Sau3A I and Acc I. The digestion was performed overnight at 2 - 3 mg DNA/ml reaction
and 1 unit enzyme/gg DNA. The 482-bp APC fragment was then enriched from the bulk
genomic DNA (see Sections 4.3.2 and 4.4) and digested with Sau3A I and Acc I to liberate
the 271 -bp fragment suitable for CDCE separation.
4.3. Evaluation of the CDGE-based approach to mutational spectrometry of
the APC target sequence in human cells
4.3.1. Overview of the approach
In the previously developed approach to detecting mutational spectra in
mitochondrial DNA, mutants were first separated from nonmutant sequences in the
presence of several micrograms of cellular DNA through CDGE, and then amplified and
enriched by a combination of high-fidelity PCR and CDCE (Khrapko et al., 1997a).
CDGE was the method of choice because of its relatively large loading capacity required for
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Figure 14. Sequential release of the desired APC gene fragment from large quantities of
human genomic DNA.
The genomic DNA was first digested with two "inexpensive" endonucleases Hae III and
Xba I to excise the 482-bp APC gene fragment (APC cDNA bp 8422-8903). A 492-bp
internal standard mutant (APC cDNA bp 8422-8913) was doped into the digestion at a
precise fraction. The APC gene fragment was then enriched from the bulk genomic DNA,
and finally subjected to digestion with the two endonucleases Sau3A I and Acc I to liberate
the 271-bp fragment (APC cDNA bp 8434-8704) suitable for CDCE analysis. The
positions of the AT -> GC transition carried by the internal standard mutant and the
recognition sites of Sau3A I and Acc I in the 482-bp fragment are indicated by arrows.
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the study.
In the earlier stage of this project, a similar approach was developed for the analysis
of the nuclear APC gene. As outlined in Fig. 15, the desired APC gene fragment was first
enriched from genomic DNA through size fractionation using PAGE after two consecutive
steps of restriction digestion. The target-enriched sample was then subjected to CDGE to
enrich mutant sequences in the presence of residual cellular DNA. The mutant-enriched
sample was amplified by high-fidelity PCR. The amplified mutants were further enriched
following two rounds of CDCE/high-fidelity PCR, and finally displayed on CDCE. This
approach was evaluated through the analysis of TK6 genomic DNA which had been doped
with known fractions of an internal standard mutant. This approach and the obtained
results are described in detail in the following sections.
4.3.2. Enrichment of the target sequence through size fractionation by PAGE
Approximately 1 mg of genomic DNA extracted from TK6 cells was digested with
Hae III and Xba I. The copy number of the target sequence in the sample was measured.
The internal standard mutant was then doped at a precise fraction (10-5 or 10-4). The
genomic DNA sample was separated by preparative PAGE. A pBR322 DNAIMsp I digest
was run in parallel serving as size markers. After electrophoresis, the gel slices containing
DNA fragments from 430 to 530 basepairs in length were excised and DNA was
electroeluted from the gels. The recovered target sequences were then digested with Sau3A
I and Acc I, and subjected to a second PAGE separation. The gel slices containing
fragments of between 230 to 410 basepairs in length were excised and DNA was recovered
by electroelution.
To estimate the level of enrichment of the target sequence, aliquots of the digested
samples were separated by PAGE, stained in ethidium bromide solution and then
photographed under a UV transilluminator. By comparing the fluorescent intensity of the
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Figure 15. Flow diagram of the CDGE-based approach to mutational spectrometry of the
APC gene target sequence in human cells.
See text for details.
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entire digest to the portion corresponding to the excised gel slice on the preparative PAGE,
the enrichment efficiency was estimated to be 50 - 100-fold in total. Based on measurement
of the target copy numbers, the overall yield of the target sequence was estimated to be
around 40%. Thus, 1 mg of genomic DNA was reduced to 10 - 20 gg containing about 8 x
107 copies of the desired 271-bp APC gene fragments.
4.3.3. Optimization of the CDGE conditions
The partially denaturing conditions in CDGE were achieved by controlling the
temperature of the TAE buffer tank where the gels were submerged during electrophoresis.
To obtain an efficient enrichment of mutants in the target-enriched genomic DNA, an
optimal separation temperature had to be determined. This was accomplished using test
runs at various temperatures. The test samples contained wild-type and artificial mutant
(mutL or mutH) fragments that were PCR amplified with primers IS 1 and IS2 and then
digested with Sau3A I and Acc I to resemble the 27 1-bp cellular APC gene fragments.
Along with the test samples, PCR amplified fluorescein-labeled hprt exon 3 wild-type and
mutant mixtures were run in parallel which served as markers.
Fig. 16 shows CDGE separations of the APC gene test samples and the hprt
markers at different temperatures. By comparing the various separation conditions, it was
determined that the optimal temperature for separating the wild-type homoduplex from the
mutant homoduplexes was 70.9'C, and that from the mutant/wild-type heteroduplexes was
70.4'C. The relative positions of the four hprt bands (two homoduplexes and two
heteroduplexes), which were visualized by illuminating the gel with a argon laser of 488
nm, would be used as markers indicating the optimal separation conditions for later
separating cellular DNA.
It was found that the CDGE separation performance was not only highly sensitive
to temperature, but also to the TAE buffer conditions (such as pH) as well. Since it was
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Figure 16. CDGE separations of the wild-type and mutant sequences in the low-melting
domain of the 27 1-bp APC gene fragment at different temperatures.
CDGE gels (17 cm x 16 cm x 0.4 mm) contained 7.5% acrylamide and 1/40 bis-acrylamide
in 1 x TAE (40 mM Tris-acetate, 1 mM EDTA, pH 8.0). The gels were polymerized with
0.1% ammonium persulfate and 0.1% TEMED. The gels were submerged in a 1 x TAE
buffer tank which was heated to the precise temperature indicated for each run.
Electrophoresis was performed at a constant voltage of 160 V for 90 min. The sample that
was separated in each lane is labeled at the top of the lane: the hprt gene exon 3 mutant and
wild-type mixture (hprt mt/wt), the APC wild-type sequence (APC wt), the APC high Tm
mutant (APC mtH), the APC high Tm mutant and wild-type mixture (APC mtH/wt), the
APC low Tm mutant (APC mtL), and the APC low Tm mutant and wild-type mixture (APC
mtL/wt). The DNA fragment corresponds to each band is indicated by a letter: a, the hprt
exon 3 wild-type homoduplex; b, the hprt exon 3 mutant homoduplex; b 1 and b2, the two
hprt exon 3 mutant/wild-type heteroduplexes; c, the APC wild-type homoduplex; d, the
APC high Tm mutant homoduplex; dl and d2, the two APC high Tm mutant/wild-type
heteroduplexes; e, the APC low Tm mutant homoduplex; el and e2, the two APC low Tm
mutant/wild-type heteroduplexes.
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impractical to refill the 20-liter CDGE tank with freshly prepared TAE after every run, it
was necessary to re-optimize the separation temperature using a pre-determined hprt marker
separation pattern as a reference before the separation of cellular DNA.
4.3.4. Pre-PCR enrichment of mutants by CDGE
Two CDGE separation approaches were tested for enriching mutants in the target-
enriched TK6 cellular DNA. One approach separated mutants in their homoduplex forms
from the excess of wild-type DNA. By excising the appropriate portions of the gel below
and above the wild-type DNA, high and low Tm mutants were enriched separately. In the
other approach, the samples were boiled and reannealed to convert all of the mutants into
mutant/wild-type heteroduplexes and then subjected to CDGE. All of the heteroduplexes
were enriched as a single preparation by excising the appropriate portion of the gel above
the wild-type DNA. DNA was then eluted from the gel slices. The elution efficiency was
determined to be about 50%.
The efficiency of mutant enrichment by CDGE was estimated by comparing the
copy number of the target sequence eluted from the gel slices that contained the enriched
mutants and the wild-type homoduplex, respectively. It was found that the enrichment was
-200-fold for high Tm mutants and -5-fold for low Tm mutants in the "homoduplex"
approach, and -10-fold for all types of mutants in the "heteroduplex" approach. The low
enrichment efficiency for the low Tm mutants and heteroduplexes was largely due to the
"tailing" phenomena produced by the wild-type DNA upon CDGE separation.
4.3.5. High-fidelity PCR and post-PCR enrichment of mutants by CDCE
The mutant-enriched samples were subjected to high-fidelity PCR using primers
API and AP4H to produce 1012 copies of the target sequence. During the PCR procedure,
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the mutants were converted into heteroduplexes in the presence of an excess of wild-type
sequence. The PCR products were separated by CDCE under the appropriate conditions so
that all of the heteroduplexes were well separated from the wild-type homoduplex and then
collected in a single fraction. The heteroduplex fraction was amplified by PCR and
subjected to a second round of CDCE/PCR procedure to further enrich and amplify the
mutant sequences. Finally, the mutants were separated in the heteroduplex forms on CDCE
(Fig. 17 and 18).
4.3.6. The detection limits of the approach
Fig. 17 shows the final CDCE display of mutant heteroduplexes derived from high
Tm mutants enriched by the CDGE "homoduplex" approach. The heteroduplexes of the
mutant internal standard at an initial fraction of 10-5 in the TK6 sample were clearly
observed. The level of the background PCR noise, which was defined as the detection
limit for the high Tm mutants, was at 10-6. Since the enrichment efficiency for the low Tm
mutants were 20-fold lower than that for the high Tm mutants, the detection limit for the
low Tm mutants in this approach was estimated to be around 2 x 10-5. Fig. 18 shows the
final CDCE display of mutant heteroduplexes derived from the TK6 genomic DNA using
the CDGE "heteroduplex" approach. Although the internal standard at an initial fraction of
10-4 was clearly observed, the internal standard at 10-5 was unobservable due to the PCR
noise. Thus the detection limit for all types of point mutants in this approach was
determined to be 10-5.
Based on the above described feasibility studies, two major drawbacks in the
CDGE-based approach were recognized. First, the detection sensitivity of the approach
was not sufficient to observe all types of point mutational hotspots in nuclear genes.
Second, the procedure of extracting DNA from gel slices was not only labor intensive, but
also produced low yields. The overall yield of the target sequence after the three
118
Figure 17. Demonstration of the sensitivity for the detection of high Tm mutations in the
APC gene target sequence in human cells through the CDGE-based approach.
About 1 mg of genomic DNA isolated from TK6 cells was subjected to the CDGE
"homoduplex" approach as described in the text. Depicted are the CDCE separations of the
high Tm mutants (in the heteroduplex form) derived from the CDCE-purified wild-type
DNA control and TK6 genomic DNA with the mutant internal standard doped at an initial
fraction of 10-5 and 10-4, respectively. CDCE was performed under the same conditions as
represented in Fig. 11. The wild-type DNA homoduplex (AT), internal standard
homoduplex (std. GC), and internal standard/wild-type heteroduplexes (std. GT and AC)
are shown as indicated.
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Figure 18. Demonstration of the sensitivity for the detection of all types of point mutations
in the APC gene target sequence in human cells through the CDGE-based approach.
About 1 mg of genomic DNA isolated from TK6 cells was subjected to the CDGE
"heteroduplex" approach as described in the text. Depicted are the final CDCE separations
of all types of mutants (in the heteroduplex form) derived from TK6 genomic DNA with
the mutant internal standard doped at an initial fraction of 10-5 and 10-4, respectively.
CDCE was performed under the same conditions as represented in Fig. 11. The wild-type
DNA homoduplex (AT) and the internal standard/wild-type heteroduplexes (std. GT and
AC) are shown as indicated.
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consecutive slab gel separation procedures (including two PAGE and one CDGE) was only
20% (= 40% x 50%). Therefore, it was concluded that the CDGE-based approach was not
suitable for the detection of mutational spectra in nuclear genes. It was necessary to
develop new methods which would have an increased efficiency of the mutant enrichment
as well as the target sequence yield.
The new strategy which is described in the following sections involved the use of
sequence-specific hybridization to obtain a higher efficiency of enrichment of the desired
APC gene fragment from the genomic DNA and then use of CDCE to achieve a higher
efficiency of separation of mutants from nonmutant sequences.
123
4.4. Development of the means to enrich the desired APC gene fragment
from genomic DNA
4.4.1. The strategy
A sequence-specific enrichment strategy was devised to replace the labor-intensive
and low-yielding PAGE method for enriching the desired target sequence from genomic
DNA. As illustrated in Fig. 19, the restriction digested genomic DNA is heat denatured
and hybridized simultaneously with excess biotin-labeled oligonucleotide probes targeted to
the Watson and Crick strands of the desired sequence. The hybrids are then captured by
streptavidin-coated paramagnetic beads and magnetically separated from the bulk DNA
solution. The target fragments are then eluted from the beads by heating, and subsequently
reannealed to form double-strands. After reannealing the mutant sequences are converted
into heteroduplexes in the presence of an excess of wild-type sequence, which then
facilitates their subsequent separation by CDCE.
4.4.2. Optimization of the experimental conditions for the APC gene fragment.
The above described strategy was applied to enrich the 482-bp APC gene fragment
excised by endonucleases Hae III and Xba I from genomic DNA. The target sequence
yield and efficiency of enrichment were monitored during the procedure by measuring the
copy numbers of the target sequence and a 205-bp mitochondrial DNA sequence
(mitochondrial bp 10011 - 10215) used as a non-target reference. The chosen
mitochondrial sequence is present at -1000 copies per TK6 and MT1 cell and has the
necessary biphasic melting profile for CDCE separation used in the copy number
measurement (Khrapko et al., 1997b; Marcelino et al., 1998). To obtain a high efficiency
of both target sequence yield and enrichment, the following experimental parameters were
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Figure 19. The strategy for sequence-specific enrichment of single-copy nuclear sequences
from genomic DNA.
See text for details.
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optimized:
(1) The biotin-labeled probes: Two 30-mer biotinylated probes, BP1 (5'-
CAAAACTGACAGCACAGAATCCAGTGGAAC-3') (APC cDNA bp 8472-8501) and
BP2 (5'-AAGACCCAGAATGGCGCTTAGGACTTTGGG-3') (complementary to APC
cDNA bp 8501-8530), were chosen to complement the Watson and Crick sequence in the
high melting domain region of the 271 -bp APC fragment, respectively. The biotin moiety
was attached to the 5' end of each probe through a 18-carbon spacer to reduce potential
steric hindrance between the probe/target hybrids and the streptavdin-coated beads.
Because the biotin-labeling efficiency of the probes (the percentage of probes that
are actually tagged with biotin) is crucial to the recovery of the target sequence, an assay
was developed to check and compare probes synthesized by various manufactures. Each
type of probe was paired with a fluorescein-labeled primer (i.e., BP1 with fluorescein
labeled AP4H, and BP2 with fluorescein-labeled API) and used in PCR of the
corresponding APC gene sequence. An excess of streptavidin-coated paramagnetic beads
was added to the final PCR solution to capture products that were extended from biotin-
labeled probes, leaving behind products extended from unlabeled probes. The amounts of
fluorescein-labeled products in the PCR solution before and after adding the beads were
then measured by CDCE to determine the percentage of products captured on the beads,
i.e., the percentage of the probes with biotin tags. Using this assay, it was found that the
biotin-labeling efficiency varied from 50 to 93% among the many different manufactures.
The probes with the highest labeling efficiency were then chosen.
(2) The hybridization conditions: The hybridization was carried out in a solution
composed of 6 x SSPE buffer (1.08 M NaCl, 60 mM sodium phosphate, pH 7.4, 6 mM
EDTA). The hybridization temperature and the molar ratio of the probe to the target were
two of the most crucial parameters affecting the yield of the target sequence. Various
hybridization temperatures ranging from 37'C to 65'C were investigated. The most optimal
temperature was determined to be between 55 and 60'C.
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Although an excess of probes relative to the target sequence was required for a high
target sequence yield, the excess of unbound probes left after hybridization would compete
with the probe-target hybrids for binding to the paramagnetic beads. As a result, large
amounts of beads would be required to completely capture the desired hybrids. The use of
large amounts of beads was not only costly but also led to an increase in nonspecific
binding to non-target DNA. Therefore, the amounts of probes used in hybridization needed
to be carefully balanced with consideration to the target sequence yield, the efficiency of
enrichment and the monetary cost. It was found that the yield increased as a function of the
probe/target molar ratio until it reached approximately 5 x 104 where by the yield started to
approach a plateau. Suitable amounts of probes for hybridization were therefore determined
to be 5 x10 4 -fold the (molar) amounts of the target sequence.
(3) The type and quantities of paramagnetic beads: The optimal type of beads for
this protocol should have a high binding capacity for biotin-tagged DNA and a low
background affinity for DNA and proteins. After a comparison study, paramagnetic beads
consisting of controlled porous glass encapsulating magnetite (CPG) were chosen. The
binding capacity of the CPG bead was found to be 6-fold higher than that of the widely
used Dynal bead (Dynal). Furthermore, preliminary results showed that the CPG beads
with a silanol (Si-OH) surface had a lower background affinity for non-target DNA than the
polystyrene made Dynal beads.
(4) The binding condition: Because a high salt concentration (> 1 M NaCl) was
recommended for optimal binding between biotin and streptavidin, pre-washed beads were
directly added to the hybridization solution to capture the probe-target hybrids. The binding
efficiency of the hybrids onto the beads was found optimal at a temperature of 45 - 50'C
(instead of room temperature recommended by the manufacture). It is conceivable that such
a high temperature might help overcome the steric hindrance that might exist between the
beads and the hybrids. It was experimentally determined that a minimum of 1 mg of the
CPG beads was required to completely capture 5 x 108 copies of the desired hybrids in the
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presence of a large excess of competing probes.
(5) The washing and eluting conditions: Once separated from the bulk DNA
solution, the beads were washed four times each with 1 M NaCl, 10 mM Tris-HCl, pH
7.6, and 2 mM EDTA buffer at 50'C for 5 min to remove nonspecific bindings of DNA and
protein. It has been reported that the nonspecific binding interaction between the DNA and
the streptavidin bound to the beads are reduced in buffers having high ionic strengths (> 1
M NaCl) (Ito et al., 1992). The beads were then washed twice with 50 mM NaCl, 1 mM
Tris-HCl, pH7.4 buffer at room temperature to reduce the amounts of salts carried over by
the beads. DNA was eluted from the beads by incubating with ddH20 at 72'C for 2 min.
The above described optimized conditions for enriching the 482-bp APC gene
fragment from genomic DNA are summarized in Table 7.
4.4.3. The enrichment efficiency and yield of the target sequence.
Up to 5 mg of genomic DNA isolated from TK6 and MT 1 cells were digested with
Hae III and Xba I and subjected to the above described target enrichment protocol.
Through this protocol, the APC target sequence was enriched over 10 4-fold relative to the
mitochondrial DNA producing a target sequence yield of between 70 to 80%. Thus, 5 mg
of genomic DNA was reduced to less than 1 gg containing 7 - 8 x 108 copies of the desired
APC gene fragments. It was found that the majority (> 95%) of the unrecovered target
sequences were still in the genomic DNA solution. These target sequences could not be
captured by additional amounts of beads, indicating that they were not hybridized to biotin-
labeled probes.
This protocol was also tested in a smaller amount ( 1 mg) of genomic DNA
isolated from human tissue samples. Although the efficiency of enrichment was more or
less the same, the target sequence yield from the genomic DNA obtained from tissues was
found to be only -50%, lower than that obtained from cultured cells. The lower yield is
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Table 7. Optimized experimental conditions for sequence-specific enrichment of the desired
APC gene fragment from digested human genomic DNA.
Experimental parameter Optimal condition
Hybridization
Biotin-labeled oligonucleotide probes > 90% labeling efficiency, 18-carbon spacer
Hybridization buffer 6 x SSCP
Hybridization temperature and time 55 - 60'C, 2 hours
Molar ratio of the probe/target sequence 5 x 104
Binding
Type of the paramagnetic bead controlled porous glass
(5 Rm, 50 nm pore diameter)
Quantities of the beads 1 mg beads per 5 x 108 copies of the target
Binding temperature and time 50'C, 1 hour
Washing
Washing buffer 1 M NaCl, 10 mM Tris-HCl,
2 mM EDTA, pH 7.6
Washing temperature and time 50'C for 5 min, repeat four times
Eluting
Eluting temperature and time 2 mg beads/ml in ddH20, 72'C for 2 min,
twice
Reannealing
Target concentration 108 copies of target/ml
Reannealing buffer 0.2 M NaCl, 10 mM Tris-HCJ,
2 mM EDTA, pH 7.6
Reannealing temperature and time 55 0C, overnight
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most probably due to the poorer purity of the tissue genomic DNA which to some extent
effected the efficiency of digestion by Hae III and Xba I. Nevertheless, it was found that
applying one or two additional round(s) of the enrichment procedure to the same genomic
DNA sample could be used to further recover the residual target sequence and increase the
overall yield to 70%.
The target-enriched samples were reannealed to double-strands and then digested
with Sau3A I and Acc I to release the 271-bp APC gene fragments suitable for CDCE
analysis. The efficiency of the Sau3A I/Acc I digestion was then measured (see Section
4.2.4). Occasionally, the digestion efficiency was found to be less than 90% indicating that
either the reannealing was not complete or that the digestion reaction was inhibited. In
most cases, the incomplete digestion was found to be due to inhibition of the restriction
enzymes by high concentrations of salts, EDTA or other impurities carried over from the
previous procedures. Simply increasing the digestion volume would usually remedy the
problem. After complete digestion, the samples were desalted and concentrated through
ultrafiltration.
4.5. Development of the means to enrich cellular mutants by wide-bore CE
4.5.1. The necessity and technical problem of using wide-bore capillaries in CDCE
It was previously shown that the CDGE separation technique was not sufficient for
the detection of mutations in the APC gene target sequence due to its low enrichment
efficiency for mutant heteroduplexes and low target sequence yield (see Section 4.3). Since
CDCE can achieve a higher separation resolution, the substitution of CDGE with CDCE
was expected to offer a more effective way to enrich mutant sequences with both a higher
efficiency of mutant enrichment and target sequence yield.
CDCE was initially developed using capillaries with 75 pm i.d.. These capillaries
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have a very limited loading capacity of no more than 80 ng of DNA. It was found that
even after the sequence-specific enrichment procedure, the sample still could not be run on
a 75 gm column CDCE due to disturbances in the local potential gradient produced by the
residual amounts of DNA and/or other impurities loaded on the column. Current drop was
observed a few minutes after starting a run.
One direct approach to increase the loading capacity of CDCE would be to use
wider bore capillaries. Theoretically, the sample loading capacity is proportional to the
capillary's cross sectional area. However, any increase in the capillary bore decreases its
surface-area-volume ratio and consequently leads to a less efficient dissipation of Joule
heating generated by the electric current. The decreased heat loss inevitably leads to a rise
in the temperature differential between the center of the capillary and its wall. Fig. 20
depicts the profile of the temperature gradient inside a capillary during electrophoresis.
Since both the DNA melting kinetics and the gel viscosity are strong functions of
temperature, the temperature gradient inside the capillary would cause a DNA velocity
gradient and thus loss in CDCE resolution.
A quantitative description of the temperature difference (AT) between the center and
wall of the capillary is given by (Knox, 1988):
AT = Q (i.d.)2 / (16K) (1)
Q = E2Ac9p (2)
where Q is the heat output per unit volume [W-cm-3], E is the field strength [V.cm-1 ], A is
the equivalent conductance of the electrolyte solution [cm 2 -W-1 -mol-1 ], c is the electrolyte
concentration [M], (p is the total porosity of the medium (=1 for open tube), and K is the
thermal conductance of the medium [W-cm-1 -K-].
4.5.2. Optimization of CDCE conditions for wide-bore capillaries.
The feasibility of using wide-bore capillaries of 250, 320 and 540 gm in CDCE
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Figure 20. Schematic representation of the temperature profile as a result of current flow
across a capillary.
(Adapted from Kuhn and Hoffstetter-Kuhn, 1993)
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was investigated. All capillaries were cut 30 cm in length with the detection window
positioned 20 cm from the capillary inlet. The length of the water jacket was 6 cm. The test
sample used for separation contained fluorescein-labeled APC gene wild-type and mutH
homoduplexes and their two heteroduplexes that were PCR amplified using primers API
and AP4H.
According to equations (1) and (2), in order to maintain a low temperature
differential (AT ) inside a large bore capillary during electrophoresis, one solution is to
reduce the applied electric field strength (E). To experimentally determine an upper field
strength limit with acceptable resolution in each wide-bore capillary, electrophoresis at
different electric field strengths was performed. Fig. 21 illustrates such a test in a 250 jim
capillary. As shown in Fig. 21 A and B, the resolution of separation was largely
maintained at lower electric field strengths of 83 V/cm (30jA) and 100 V/cm (40 gA).
When the field strength increased to 127 V/cm (50 jiA), the resolution decreased (Fig. 21
C). At 150 V/cm (60 gA), distorted peaks appeared, a result of over-heating near the
center of the capillary (Fig. 21 D). From an evaluation of both the resolution and the
separation times, 100 V/cm was determined to be the most suitable field strength for CDCE
in 250 jim capillary.
Note that due to the highly temperature-sensitive nature of CDCE separation (Fig.
11 and 12), an increase in the electric field strength causes a rise in the overall intracapillary
temperature and a change in the separation pattern. In order to obtain the same separation
pattern at different electric fields, the water bath temperature was adjusted to counteract the
intracapillary temperature difference. As indicated in Fig. 21, the water jacket temperature
was set at 62.6, 62.5, 62.4 and 62.3C for CDCE at 30, 40, 50 and 60 gA, respectively.
Suitable electrophoretic conditions (both field strengths and water jacket
temperature) were determined in the other two wide-bore capillaries with 320 and 540 jim
bores following a similar experimental process. The field strengths were 73 V/cm and 50
V/cm for the 320 and 540 jim capillaries, respectively. The CDCE separations using the 75
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Figure 21. CDCE separation performance in a 250 tm i.d. capillary at different electric
field strengths.
(A) 83 V/cm, 30 pA, 62.6'C. (B) 100 V/cm, 40 gA, 62.5'C. (C) 127 V/cm, 50 gA
constant, 62.4'C. (D) 150 V/cm, 60 gA, 62.3'C. The temperature indicated is that of the
water-jacket set for each run. Approximately 109 copies of fluorescein labeled PCR
fragments were loaded onto the capillary.
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Figure 22. Comparison of CDCE separation performance using capillaries of various sizes.
(A) 75 pm, 260 V/cm, 9.0 gA, 62.5'C. (B) 250 gm, 100 V/cm, 40 gA, 62.5 0C. (C) 320
gm, 90 V/cm, 50 gA, 62.50 C. (D) 540 gm, 60 V/cm, 80 gA, 62.6 0C. 109 - 1010 copies of
fluorescein labeled PCR fragments were loaded onto each capillary.
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pm narrow-bore and 250, 320, 540 pm wide-bore capillaries were compared in Fig. 22.
The results show that the resolution of CDCE separation can be maintained in wide-bore
capillaries when the electric field strength is correspondingly reduced.
According to equations (1) and (2) (on Page 131), the ratio of the intracapillary
temperature difference of the wide-bore capillary to that of the 75 gm capillary
(ATwb/AT75) was calculated based on the experimentally determined suitable electric field
strengths (Table 8). Calculations show that ATwb of each wide capillary is higher than
AT 75 (ATwb/AT75 > 1) under the given operational conditions. This indicates that low
electric field strength has a beneficial effect on the CDCE separation in addition to
producing less Joule heat (Khrapko et al., 1996), making separations in wide capillaries
relatively more tolerable to the intracapillary temperature gradient.
Theoretical calculations also suggested the use of lower electrolyte concentrations
for reducing the heat output (Knox, 1988; Grushka et al., 1989). At lower electrolyte
concentrations, higher electric field strengths might be applied without diminishing
resolution. However, it was found in this study that as the electrolyte concentrations in
both linear polyacrylamide and electrophoretic buffer were reduced by half (from 1 x TBE
to 0.5 x TBE), the peaks broadened and the resolution decreased. Since the amount of
sample injected (0.1 - 0.01 pmol) was too low to cause inhomogeneity in the electrical field
within the capillary (Mikkers et al., 1979; Jorgenson et al., 1983), one reason for the
observed peak broadening at low electrolyte concentration could be due to the reduction of
cations which through their interaction with the negatively charged phosphate groups in the
DNA strands, facilitate the DNA melting equilibrium process on which separation is based.
It is clear that in the CDCE system, the undesirable effect of low electrolyte concentration
on the separation negates its beneficial effect of producing less heat. One potential solution
could be to replace TBE with a buffer having a lower electric conductance but with equal or
higher ionic strength (Reijenga et al., 1996).
140
Table 8. Experimental and calculated parameters for CDCE in capillaries of various
bore widths.
Field Strength
(V/cm)
260
100
73
Temperature
(OC)
62.5
62.5
62.5
Calculated
AT b/AT 75a
1.6
1.4
540 I 80 I 50 1 62.6 1 1.9
a According to equations (1) and (2), ATwb/AT75 = {(i.d. of wb/75 gm)-(Ewb/E75)} 2 .
ATwb: temperature difference inside a wide-bore capillary,
AT 75 : temperature difference inside a 75 gm capillary,
Ewb: electric field strength applied across a wide-bore capillary,
E75 : electric field strength applied across a 75 gim capillary.
Capillary
i.d. (gin)
75
250
320
Current
(pA)
9
40
50
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4.5.3. Determination of the DNA loading capacities for capillaries of various sizes.
To determine the DNA loading capacities for capillaries as a function of bore
diameter, various amounts of restriction digested human DNA containing the set of
fluorescein labeled PCR products were introduced into each capillary through electrokinetic
injection and the quality of separation was evaluated. Loading was conducted at 50 V/cm
for 2 minutes through a Teflon tube tightly mounted onto the end of capillary. This method
was able to completely load known copy numbers of fluorescein-labeled DNA fragments
(Khrapko et al., 1994). Our expectation was that loading capacity would be approximately
proportional to the cross sectional area of the capillary (Rose and Jorgenson, 1988).
Electrophoresis was performed under the previously defined operational conditions
for each capillary bore width (Fig. 22). The electropherograms show that the loading
capacity of CDCE was indeed increased with bore width (Fig. 23). A 75 jim capillary
shows good separations up to 80 ng (Fig. 23A), a 250 gm bore up to 2.0 jg (Fig. 23B), a
320 jim bore up to 2.5 jg (Fig. 23C) and a 540 jm bore even up to 10 jig (Fig. 23D). It
can be seen, however, that at high sample loads, peaks become broader and/or distorted.
Larger amounts than those shown resulted in a current drop in all capillaries. The
deterioration of resolution and instability of current at excessive sample loading could be
explained by the difference in electrical conductivity of the DNA and the electrophoretic
medium (Mikkers et al., 1979; Jorgenson et al., 1983; Lauer et al., 1986). High sample
concentration in the capillary column can cause disturbances in the local potential gradient.
Local over-heating in the sample zone can occur, resulting in broadened and distorted
peaks.
One could therefore define DNA loading capacity as the maximum amount of DNA
that the capillary can accommodate without observable perturbation to the potential and
current while still showing adequate resolution. Using this definition for restriction
digested human genomic DNA, the DNA loading capacities for capillaries of the various
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Figure 23. CDCE separation performance as a function of amount of DNA loaded on
capillaries of various sizes.
(A) 75 tm, 20, 50 and 80 ng. (B) 250 jim, 1.0, 1.5 and 2.0 jig. (C) 320 jim, 1.5, 2.0 and
2.5 jg. (D) 540 jim, 3, 5 and 10 jig.
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bores were found to be 80 ng for 75 jim, 2.0 jig for 250 jim, 2.5 jg for 320 jm, and 10
jig for 540 jm, respectively.
4.5.4. Demonstration of the detection sensitivity in reconstruction experiments
The efficiency of mutant enrichment by CDCE in a 540-pm capillary was first
tested in reconstruction experiments. 2 x 108 copies of CDCE-purified wild-type APC gene
fragments (271 -bp) were doped with known copies of artificial mutant/wild-type
heteroduplex fragments (271-bp) at a mutant fraction of 0, 10-6 and 10-5, respectively.
About 2 jig of digested genomic DNA was added to each sample to mimic the presence of
residual amounts of cellular DNA known to exist after sequence-specific enrichment of the
target sequence.
The samples were separated by CDCE in a 19.5-cm long, 540 jm i.d. column
inserted into a 6-cm water-jacket. The electrophoresis was conducted at a constant current
of 80 jiA. An appropriate temperature was used at which all heteroduplexes coalesced
within a single fraction that was well separated from the wild-type homoduplex. The
desired heteroduplex fraction was then collected. By comparing the copy number of the
target sequence loaded onto the column to that in the heteroduplex collection, the
enrichment efficiency of heteroduplexes was estimated to be 200 - 250-fold.
The heteroduplex collections were subjected to high-fidelity PCR. The amplified
mutants were further enriched and amplified by two successive rounds of CDCE (in a 75
pm i.d. column) coupled with high-fidelity PCR, and finally displayed on CDCE (Fig.
24). The internal standard heteroduplexes at an initial fraction of 10-6 were clearly
observable above the background PCR noise (Fig. 24). The results of the reconstruction
experiments demonstrated that a highly efficient enrichment of mutant heteroduplexes could
be obtained by CDCE separation using a 540 jm i.d. capillary in order to observe
mutations at fractions as low as 10-6.
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Figure 24. Reconstruction experiments demonstrating the detection sensitivity using wide-
bore (540 gm i.d.) CDCE for pre-PCR mutant enrichment.
CDCE-purified wild-type DNA samples doped with internal standard at 0, 10-6 and 10-5,
respectively, were subjected to the procedure of wide-bore CDCE -> high-fidelity PCR ->
2 x [CDCE-PCR]. Depicted are the final CDCE separations of mutant heteroduplexes. The
wild-type homoduplex and the internal standard heteroduplexes (GT and AC) are shown as
indicated.
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4.5.5. Enrichment of mutant/wild-type heteroduplexes from target-enriched genomic DNA
In order to use CDCE to separate unlabeled cellular DNA, optimal separation
temperatures and the collection times for the desired fractions had to be pre-determined
using fluorescein-labeled PCR fragments. The same CDCE conditions were then applied to
the cellular DNA in "blind" runs. The performance of the separation was then checked by
measuring the copy number of the target sequence in each of the collected fractions.
When the cellular DNA enriched for the 271 -bp APC gene fragment was subjected
to CDCE in a 540 Jtm capillary under optimal conditions, 5% of the wild-type DNA loaded
onto the column was found co-eluted in the heteroduplex fraction. That is, the efficiency of
enriching mutant heteroduplexes was only 20-fold as compared to over 200-fold as
observed in the reconstruction experiments with CDCE-purified wild-type DNA. Based on
the level of PCR noise (Fig. 24), a 20-fold pre-PCR enrichment would only allow
observation of mutants at fractions at or above 10-5. It was clear that further enrichment of
the cellular mutants prior to high-fidelity PCR was necessary. For further CE separation,
the collected heteroduplex fraction was desalted by drop dialysis and concentrated through
speed-vac.
At first, a second CDCE was attempted to further separate the heteroduplexes from
the residual wild-type sequences. However, it was found that the mutants in the first
heteroduplex fraction were enriched to less than 2-fold following the second CDCE step.
The fact that the second CDCE failed to separate the residual wild-type DNA from the
heteroduplexes suggested that the main component of the wild-type DNA in the CDCE
heteroduplex was not part of the homogenous "tail" of the normal wild-type homoduplex
peak. This residual wild-type DNA could exist in other conformations which had a
electrophoretic mobility that coincided with the heteroduplexes on CDCE.
CE at room temperature was then used to separate the first heteroduplex fraction.
It turned out that only 10 - 20% of the residual wild-type sequences were found in the
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fraction containing the expected 271-bp target fragment, while the remainder were found
distributed in fractions collected after the 271-bp double-strand peak. This indicated that
the majority of the wild-type sequences which migrated within the heteroduplex fraction on
CDCE could be of longer length and/or contained single-strand structure. These wild-type
sequences could have been generated due to incomplete restriction digestion, heat-induced
strand breaks and/or non-specific reannealing during the earlier procedures. The second
separation by CE at room temperature thus achieved an additional 5 - 10-fold enrichment of
the mutants.
Taken together, it was found that through a combination of CDCE and CE at room
temperature in a 540 xm i.d. column, the rare mutant sequences in the target-enriched
cellular DNA samples could be enriched 100 - 200-fold against the abundant wild-type
DNA. This high efficiency of enrichment prior to PCR was necessary in order to observe
mutants at fractions as low as 10-6. As compared to the slab gel CDGE technique, the
major advantage of CDCE is its ability to recover the desired fractions through on-column
electroelution with a high yield (almost 100%). This high efficiency of recovery permits
two consecutive CE separation steps to be carried out for enriching the mutant sequences in
the target-enriched cellular DNA.
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4.6. The CDCE/high-fidelity PCR approach to mutational spectrometry of
the APC target sequence in human cells: application to MNNG-treated MT1
cells
4.6.1. Overview of the approach
The improved CDCE/high-fidelity PCR approach incorporated the above described
two technical developments which involved the use of sequence-specific hybridization to
enrich for the target sequences and wide-bore CE to enrich for mutant sequences prior to
PCR. In this approach (Fig. 25), large quantities (up to 10 mg) of genomic DNA were
digested with two "inexpensive" endonucleases Hae III and Xba I to liberate the target
sequence embedded in a 482-bp APC gene fragment (cDNA bp 8422 - 8903). The copy
number of the target sequence was measured by quantitative PCR coupled with CDCE.
Known copies of a 492-bp artificial mutant used as an internal standard were then
introduced into the sample for determination of the initial fractions of the cellular mutants
observed at the end of the procedures. The desired APC gene fragments were enriched
from the bulk genomic DNA digest through sequence-specific hybridization coupled with
magnetic separation. The target-enriched cellular DNA was concentrated and reannealed to
form double-strands and resulted in rare mutant sequences being converted into
mutant/wild-type heteroduplexes. The sample was then digested with two "expensive"
endonucleases Sau3A I and Acc I to release the desired 271 -bp APC gene fragment (cDNA
bp 8434 - 8704) suitable for CDCE separation.
After desalting and concentration, the sample was subjected to wide-bore CDCE in
a 540 tm i.d. capillary to separate the heteroduplexes from an excess of wild-type
homoduplex in the presence of residual cellular DNA. CDCE was performed at an optimal
temperature at which all heteroduplexes coalesced within a single fraction that was well
separated from the wild-type homoduplex. All heteroduplexes were electroeluted into a
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Figure 25. Flow diagram of the CDCE/high-fidelity PCR approach to mutational
spectrometry of the 121 -bp APC gene target sequence in human cells.
See text for details.
Genomic DNA
Digestion with Hae III and Xba I
PCR, CDCE Copy number
measurement
Introduction of the internal standard,
Sequence-specific enrichment
Digested DNA enriched for the
target fragments in single-strands
Concentration and reannealing
Reannealed DNA containing
mutant/wt heteroduplexes
Digestion with Sau3A I and Acc I
Digested DNA enriched for the
271-bp APC gene fragments
Desalting and concentration
Enrichment of heteroduplexes by
CDCE in a 540 urn i.d. capillary
Collected heteroduplex
fraction enriched for mutants
Further enrichment of mutants
by CE at room temperature
in a 540 pm i.d. capillary
Collected 271 -bp ds fraction
further enriched for mutants
Hifi PCR
Fluorescein-labeled PCR products -
of the 243-bp APC gene fragment
Post-PCR enrichment by
CDCE in a 75 gm i.d. capillary
Collected heteroduplex Ix
fraction enriched for mutants
Hifi PCR
Display of mutational spectra I
Digested DNA containing the
482-bp APC gene fragment
152
single fraction. The collected heteroduplex fraction was desalted by drop dialysis and
subjected to wide-bore CE at room temperature to further separate the heteroduplexes from
the residual wild-type DNA in unknown "cryptic" forms. The fraction containing the
normal 27 1-bp APC gene fragments was collected to further enrich the mutant sequences.
The mutant-enriched cellular DNA was amplified by high-fidelity PCR using native
Pfu DNA polymerase to yield fluorescein-labeled 243-bp APC gene fragments (cDNA bp
8441-8683). The PCR products were subjected to CDCE in a 75 lim i.d. capillary to
separate the mutant/wild-type heteroduplexes from the wild-type homoduplex. The
heteroduplexes were collected in a single fraction and again amplified by high-fidelity PCR.
The CDCE/high-fidelity PCR procedure was repeated once more to further enrich the
mutants. Finally, the mutant and wild-type homoduplex mixtures were separated on
CDCE. Mutant peaks were then individually isolated and sequenced to obtain the
mutational spectrum.
4.6.2. Application to MNNG-treated and untreated MT1 cells
The mutational spectrometry approach described above was tested by measuring
MNNG induced point mutations in the 121-bp APC target sequence in human
lymphoblastoid MT 1 cells. MT 1 cells are highly resistant to the cytotoxicity of MNNG, but
remain sensitive to its mutagenicity, a feature that allows treatment of the cells with a large
dosage of MNNG to induce high mutant fractions in nuclear genes (Goldmacher et al.,
1986; Kat et al., 1993). In this study, exponentially growing MT1 cultures consisting of 8
x 107 cells were exposed to 4 jiM MNNG for 45 min. This treatment killed 20% of the
cells and induced a hprt mutant fraction of 8 x 10-3. After treatment the cells were grown
for 30 doublings with daily dilution to dilute unrepaired premutagenic lesions (- 5 x 104
0 6-meG/cell) (Goldmacher et al., 1986) which could be mistaken for mutations by the
procedures.
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Approximately 4.5 mg of genomic DNA was isolated from 5 x 108 MT1 cells.
After digestion with Hae IJIIXba I, the internal standard mutant was introduced at an initial
fraction of 10-5 in one MNNG-treated and two untreated MT1 genomic DNA samples, and
2 x 10-5 in the other MNNG-treated MT1 genomic DNA sample. Subsequent sequence-
specific enrichment achieved over 10,000-fold enrichment of the target sequences with a
yield greater than 70%. Thus the amount of cellular DNA in each sample was reduced to
less than 1 gg containing 7 x 108 copies of the target sequences. Prior to CE separation, the
sample was desalted and concentrated through ultrafiltration in order to be electro-injected
on the capillary. This procedure resulted in 50% yield of the target sequences.
About 2 x 108 copies of the target sequences from each sample including a CDCE-
purified wild-type DNA control were subjected to wide-bore CDCE and then CE at room
temperature. Based on measurements of the copy number of the target sequence loaded on
the column and that eluted in the mutant-containing fraction, the efficiency of mutant
enrichment after the two CE separation procedures was determined to be 100 - 200-fold.
The mutant-enriched samples which contained approximately 106 copies of target
sequences were amplified by high-fidelity PCR using primers API and AP4H to yield
nearly 2.5 x 1012 copies of fluorescein-labeled APC gene fragment. The amplified mutant
sequences in their heteroduplex forms were further enriched 100-fold by two rounds of
CDCE coupled with high-fidelity PCR (Fig. 26). The mutants were converted into
homoduplexes following a few cycles of PCR with an excess of remaining primers to
prevent the formation of heteroduplexes. In order to separate the complex mixtures of
homoduplexes on CDCE at a high resolution, separations were operated at a low electric
field strength and using an extended water-jacket to increase the average number of partial
meltings and reannealings a molecule undergoes while in the heated zone of the capillary.
Fig. 27 shows the final CDCE separations of mutant homoduplexes derived from
the CDCE-purified wild-type DNA, two untreated and two MNNG-treated MT 1 cultures.
It can be seen that both MNNG-treated MT1 samples contained a distinct set of low Tm
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Figure 26. Post-PCR enrichment of the amplified mutant sequences by CDCE coupled with
high-fidelity PCR.
Depicted are CDCE separations of fluorescein-labeled PCR products (about 2 x 108 copies
of the target fragments) derived from the MNNG-treated MT 1 cells. The wild-type peak in
both electropherograms is shown in 1/10 of its full height. (A) After CDCE and CE at room
temperature in a 540 pm i.d. capillary, the mutant-enriched sample was subjected to 40
cycles of high-fidelity PCR. The PCR products were separated by CDCE in a 75 gm i.d.
capillary at 9 ptA and using a 6-cm water-jacket at 64.6'C. The heteroduplex fraction was
collected. The broad peak marked by 'X' is a PCR byproduct generated after direct
amplification of genomic DNA. (B) The above collected heteroduplex fraction was
subjected to 38 cycles of PCR and separated by CDCE. The heteroduplex fraction was then
collected and amplified to further enrich the mutants.
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X heteroduplex fraction
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Figure 27. CDCE separations of the mutant homoduplexes derived from the CDCE-
purified wild-type DNA, two untreated and two MNNG-treated MT1 genomic DNA
samples.
CDCE was performed at 8 gA and using a 19-cm water-jacket at 65.20'C. The wild-type
peak and the internal standard (std.) at its initial mutant fraction in each cellular sample are
indicated. The std. peak is shown at 1/2 of its full height in "Untreated MT1 #1",
"Untreated MT1 #2" and "MNNG-treated MTl #1" samples, and 1/4 of its full height in
"MNNG-treated MT1 #2". Mutant peaks that have been isolated and sequenced are
designated by letters (a to n) in the untreated sample and numbers (1 to 15) in the treated
sample. "SS" marks single-strand DNA. "X" and "Y" indicate unknown PCR artifacts.
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mutant peaks above the background mutations observed in the CDCE-purified wild-type
DNA control and two untreated MT1 samples. The peak pattern exhibited excellent
reproducibility in each replicate samples. In the high Tm mutant region, except for peaks X
and Y, no significant difference was observed among the analyzed samples (Fig. 27).
Peaks X and Y were proven to be PCR artifacts since they were also observed in PCR
products directly amplified from genomic DNA (see Fig. 33).
4.6.3. Identification of the mutant peaks
The individual mutant peaks displayed on the CDCE electropherogram (Fig. 27)
were isolated and sequenced. Typically two to four rounds of CDCE collection and PCR
were required to adequately purify a mutant peak for DNA sequencing. To confirm the
isolated mutant was indeed the desired one, the purified product was co-injected with the
original mutant mixture and run on CDCE to verify comigration with the desired peak. The
PCR products of the purified mutants were desalted and removed from residual primers by
ultrafiltration before being submitted for sequencing.
Fourteen mutations designated by letters a to n in the untreated MT1 sample and
fifteen mutants designated by numbers 1 to 15 in the MNNG-treated MT I sample (Fig. 27)
were purified and sequenced. All of the mutants were single base pair substitutions as
shown in the target sequence context in Fig. 28. All of the fourteen mutants in the
untreated sample were GC -> TA transversions. In contrast, twelve out of the fifteen
mutants identified in the treated sample were GC -> AT transitions. The three exceptions
(peaks 1, 10 and 12) were GC -> TA transversions which were identical to peaks a, h and
j, respectively, in the untreated control, suggesting that they belong to the set of
background mutations.
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Figure 28. Distribution of base substitutions in the APC gene target sequence (cDNA bp
8543-8663) in MNNG-treated and untreated MT1 cells.
Mutations from the MNNG-treated MT 1 cells (labeled with numbers) are shown above the
wild-type sequence, while those from the untreated MT1 cells (labeled with letters) are
below the sequence. The mutation labels correspond to those in Fig. 27. The base
substitution of the internal standard (std.) is also indicated.
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4.6.4. MNNG-induced point mutational spectrum in the APC target sequence
The twelve GC -> AT transitions which were reproducibly observed in the MNNG-
treated samples but absent in the untreated controls were consistent with the miscoding
potential of 0 6 -meG lesions produced by MNNG (Loveless, 1969; Loechler et al., 1984).
By comparison to the area under the internal standard peak, the total mutant fraction
induced by MNNG in MTl cells was estimated to be 8.2 x 10-5 after subtracting the
background signals derived from the untreated cells.
To obtain an accurate measurement of the area under each mutant peak, CDCE was
performed at various temperatures, and for each peak to be measured, the appropriate
electropherogram showing the best separation of this peak from its adjacent ones was
chosen. By comparison of the area under each mutant peak with that under the internal
standard peak, the mutant fractions of the 12 transition mutations were estimated to be
between 2.2 x 10-6 and 9.2 x 10-6, and are highly reproducible in the replicate samples
(Table 9). Fig. 29 shows the MNNG-induced point mutational spectrum in the 121-bp
APC gene target sequence with regard to kind, position and mutant fraction.
The 121 base pairs of the target sequence contain 29 guanine residues; 18 of these
sites are preceded (5') by a purine, at which 11 (peaks 2, 3, 4, 6, 7, 8, 9, 11, 13, 14 and
15) were mutated at a total fraction of 5.9 x 10-5. The remaining 11 guanine sites are
preceded (5') by a pyrimidine, at which only one (peak 5) was mutated at a fraction of 5.6
x 10-6. Assuming all of the GC -> AT transitions resulted from 0 6 -meG, then guanine
residues preceded by a purine were on average more than 6 times as likely to be mutated
(3.3 x 10-6/site) as those preceded by a pyrimidine (5 x 10- 7/site) in the APC target
sequence. This difference is highly significant (P < 0.001 based on X2 tests).
An analysis of strand distribution of these transitions showed that 8 of the 12
mutated guanines (peak 2, 3, 4, 5, 7, 8, 9 and 14) resided on the non-transcribed strand
which contains 19 guanines with II preceded by a purine. The other 4 mutated guanines
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Table 9. Positions and estimated mutant fractions of the twelve MNNG
-induced GC -> AT transitions in the two replicate MT 1 cell cultures.
Estimated mutant fraction (x10-6)
Mutation a APC cDNA bpMT#1 T12 Avrg
MTI #1 MT l #2 Average
2 8553 5.1 4.8 5.0
3 8561 7.1 6.3 6.7
4 8555 4.0 2.8 3.4
5 8565 5.5 5.6 5.6
6 8580 7.4 7.6 7.5
7 8634 3.7 4.4 4.1
8 8656 9.1 9.2 9.2
9 8605 2.7 2.0 2.4
11 8626 6.8 7.9 7.4
13 8595 6.3 6.7 6.5
14 8573 2.3 2.1 2.2
15 8598 4.4 3.9 4.2
(a ) The mutant numbers correspond to those in Fig. 27.
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Figure 29. MNNG-induced point mutational spectrum in the APC gene target sequence in
MT1 cells.
The horizontal axis represents the APC target sequence from cDNA bp 8543 to 8663. Each
mutant is labeled with a number corresponding to that in Fig. 27 and 28. The height of
vertical bar represents the average fraction of each mutant in the replicate MNNG-treated
MT1 cells. All mutants were GC -> AT transitions. Except for one which is indicated by
'*', all transitions occurred at G residues preceded (5') by a purine. Filled bars represent
mutants at guanine residues residing on the nontranscribed strand, open bars represent
mutants at guanine residues on the transcribed strand.
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(peak 6, 11, 13 and 15) were on the transcribed strand which contains 10 guanines with 7
preceded by a purine. The average mutant fraction of GC -> AT transitions was 2.1 x 10-
6 /site (or 3.1 x 10-6/site preceded by a purine) on the nontranscribed strand, and 2.5 x 10-6
/site (or 3.6 x 10-6/site preceded by a purine) on the transcribed strand. The MNNG-
induced mutations in the APC target sequence therefore did not exhibit a significant strand
bias.
4.6.5. Comparison to previous MNNG mutagenesis studies
In our laboratory, MNNG-induced point mutational hotspots were previously
investigated in the hprt gene in MT1 cells using phenotypic selection. MT1 cells were
twice treated with 4 gM MNNG which induced a hprt mutant fraction of 1.2 x 10-2 (Kat,
1992). Eleven GC -> AT hotspots were identified with each representing 1 to 10% of the
total 6TGR mutants (Kat, 1992). In this study, treatment of MT1 cells with a single dose
of 4 gM MNNG induced a hprt mutant fraction of 8 x 10-3. Assuming the target size of the
hprt gene is 1000-bp, then one induced hotspot at or above 1% of the mutant population
would be expected to occur in a given 100-bp nuclear sequence based on Kat's study
(1992). The mutant fraction of such a hotspot prior to phenotypic selection would be 8 x
10-5. The 121-bp APC target sequence was vacant for such a prominent hotspot. The
vacancy observed in this APC particular target sequence was reminiscent of that in the 100-
bp hprt exon 3 low melting domain (Kat, 1992). Both sequences are low in GC content,
which may make them relatively poor targets for MNNG mutagenesis. Nevertheless,
owning to the high sensitivity of the CDCE/high-fidelity PCR approach, twelve MNNG-
induced "cold" spots at fractions between 2.2 x 10-6 and 9.2 x 10-6 were detected in the
APC target sequence.
The MNNG mutagenic specificity observed in this study can be compared with that
obtained in bacteria, yeast and other human systems based on phenotypic selection
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(Horsfall et al., 1990; Gordon et al., 1990; Burns et al., 1987; Richardson et al., 1987;
Reed and Hutchinson, 1987; Kohalmi and Kunz, 1988; Yang et al., 1991; Lukash et al.,
1991; Kat, 1992). The results in this study agree with the previous observations that
MNNG specifically induces GC -> AT transitions which predominantly occur at guanine
residues preceded (5') by a purine. The kind of mutation is consistent with the miscoding
potential of 0 6-meG (with thymine) which is believed to be the major premutagenic lesion
produced by MNNG (Loveless, 1969; Loechler et al., 1984). It has been suggested that
the 5' flanking base may influence the initial deposition of 0 6-meG lesions and/or the
fidelity of a DNA polymerase bypassing these lesions (Gordon et al., 1990).
An analysis of strand distribution of the twelve MNNG-induced transitions in the
APC target sequence revealed no strand bias. The absence of a strand specificity has also
been observed in other targets (Gordon et al., 1990; Kohalmi and Kunz, 1988). However,
several studies including those on the endogenous hprt gene in human cells have reported a
strand preference in favor of GC -> AT transitions at guanines on the nontranscribed strand
(Richardson et al., 1987; Reed and Hutchinson, 1987; Yang et al., 1991; Lukash et al.,
1991; Kat, 1992). It has been suggested that the non-random distribution of MNNG-
induced mutation in some targets could be a reflection of the influence of the mutation on
protein structure and function (Gordon and Glickman, 1988). For example, a GC -> AT
transition in the Gly (5'-GGN-3') and Trp (5'-UGG-3') codon sequences is more likely to
be selected as a hotspot because Gly residues are often strategic to protein structure and the
transition in Trp coding sequence results in a translation termination signal. The results
obtained in the 121-bp APC gene sequence without the use of phenotypic selection provide
further support to the view that the strand specificity of MNNG-induced mutation in some
target sequences may reflect an observation skewed by phenotypic selection.
4.6.6. Sources for the background mutations observed in untreated cells
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The background mutational spectrum in untreated MT1 cells consisted of fourteen
identified GC -> TA transversions ranging in mutant fraction from 4 x 10-7 to 1.7 x 10-6 as
compared to the internal standard (Figs 27, 28). These background mutations could have
come from several possible sources, including: (1) true spontaneous mutations in MT1
cells; (2) DNA adducts and/or replication mismatch intermediates existing in the cells which
were later converted into mutations by Pfu DNA polymerase; (3) DNA lesions produced by
the procedures; or (4) PCR-introduced noise including newly created mutations by Pfu
polymerase misincorporation errors or DNA lesions generated during PCR which were
converted into mutations.
To discover whether any of these transversions actually represent true spontaneous
mutations in MTl cells, genomic DNA of TK6 cells was subjected to the cascade of the
entire procedure. TK6 is the isogenic GTBP normal parent line of MTI with a spontaneous
mutation rate that is 15-fold lower than that of MT1 (Goldmacher et al., 1986). Previous
studies have shown that these two cell lines exhibit distinct spontaneous mutational spectra
in the hprt gene (see Fig. 7 on Page 68) (Cariello et al., 1990; Kat, 1992; Kat et al., 1993;
Tomita-Mitchell et al., unpublished results). In this study, however, the same set of
transversion mutations in MT1 cells was also observed in TK6 genomic DNA (Fig. 30).
The results indicate that these background mutations are unlikely to exist as true mutants in
the cells.
When the low Tm mutant regions of the CDCE electropherograms (shown in Fig.
27) were magnified for the PCR noise control and the two untreated MT l cells (Fig. 31), a
great similarity in the peak pattern was observed among the three samples. These
observations indicate that PCR-introduced noise could be a significant source for the
background mutations. Three of the mutant peaks (designated by the symbols X, P and 6)
derived from the CDCE-purified wild-type DNA were then isolated and sequenced (Fig.
31). All three mutations were found to consist of GC -> TA transversions. Mutations a
and 3 were found to be identical to mutations a and h, respectively, isolated from the
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Figure 30. CDCE separations of the mutant homoduplexes derived from TK6 cells.
Three milligrams of genomic DNA isolated from TK6 cells were subjected to the
previously described mutational spectral analysis. CDCE was performed at 8 gA using a
19-cm long water-jacket at a temperature of 64.40'C. The mutant peaks are labeled
corresponding to those shown in Fig. 27.
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Figure 31. Comparison of CDCE separations of low Tm mutants derived from the CDCE-
purified wild-type DNA and untreated MT 1 cells.
Depicted are the magnification of the regions corresponding to the migration time ranging
between 27 and 42 minutes in the CDCE electropherograms shown in Fig. 27 and that of
the CDCE-purified wild-type DNA before PCR. The kinds and positions of the three
mutant peaks (designated by symbols c, P and 8) that have been identified in the PCR
control are shown. "*" indicates an unidentified peak observed in the untreated MT1 #2
sample that comigrated with peak 6. "SS" marks single-strand.
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untreated cells. Mutation 6, which occurred at the position of APC cDNA bp 8638, was
not found among the fourteen mutations that were identified from the untreated cells.
However, peak 6 seemed to comigrate with an unidentified peak (*) located between peaks
k and 1 in the untreated cells (Fig. 31).
To verify that the mutations derived from the purified wild-type DNA control were
indeed created during the PCR process, independent PCR experiments were then
performed. The wild-type sequence was amplified from TK6 genomic DNA using primers
AP 1 and AP4H and purified by CDCE. The purified wild-type DNA was then doped with
an internal standard at a mutant fraction of 10-3. Using Pfu DNA polymerase, 4 x 107
copies of the template were first amplified to a total of 1012 copies (15 doublings). Then 4
x 107 copies of the diluted PCR products were amplified to 1012 copies to obtain another
15 doublings. The mutant sequences in the PCR products (after 15 and 30 doublings)
were enriched by two rounds of CDCE coupled with PCR, and then separated on CDCE in
their homoduplex forms (Fig. 32). It was observed that most of the mutant peaks
(including peaks c, P and 6) increased in their mutant fractions from 15 to 30 doublings,
proving that these peaks were created by PCR.
Interestingly, a GC -> TA transversion was also found to be one of the most
prominent Pfu-induced mutational hotspots in a 96-bp human mitochondrial DNA
(mitochondrial bp 10031-10126), and actually the most prominent hotpot among all of the
low Tm mutant peaks observed in this sequence (Andre et al., 1997). The Pfu-induced GC
-> TA transversions could be created by several possible mechanisms, including: (l)Pfu
polymerase misincorporation errors and failure of its proofreading activity, (2) polymerase
microheterogeneity (a subset of error-prone polymerase molecules due to mistranscription,
mistranslation, or chemical modifications of the normal polymerase), (3) heat-induced
mutagenesis (such as depurination), or (4) chemical modifications in the nucleotide pool
(such as the spontaneous formation of 8-hydroxyguanine) (Andr6 et al., 1997).
Preliminary studies showed that variations in denaturation time at 94'C did not affect the
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Figure 32. CDCE separations of mutant homoduplexes induced by PCR using Pfu DNA
polymerase after 15 and 30 doublings.
CDCE was performed at 8 gA and using a 19-cm water-jacket at 64.50'C. The wild-type
DNA and the internal standard (std.) which was at an initial fraction of 10-3 are shown. The
std. peak is shown at 1/4 of its full height in all samples. The mutant peaks that have been
identified are labeled by the symbols cx, P and 6. The mutant labels correspond to Fig. 30.
The duplicate sample for 30 doublings is shown here to demonstrate the reproducibility of
the experiments.
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level of the mutant fraction induced by PCR, suggesting that heat-induced DNA lesions are
unlikely to be the main origin of PCR noise (Paulo Andr6, personal communication).
The mutant fractions of the low Tm mutants (between 29 - 41 min) in the
independent PCR experiments were plotted as a function of the number of doublings in
Fig. 33. Using linear regression analysis, the slope was determined to be 8.2 x 10-3 total
low Tm mutations per doubling (Fig. 33). In comparison, in both untreated MTl samples,
21 doublings (from 106 to 2.5 x 1012 copies) was performed to amplify the mutant-
enriched cellular DNA. Given that the internal standard was present at a mutant fraction of
- 10-3 after pre-PCR mutant enrichment, the total mutant fraction of the low Tm mutants
(between 29 - 41 min) was estimated to be 2.2 - 2.4 x 10-3 in the final PCR products (Fig.
27). The observed mutant fraction in the untreated MT1 samples was somewhat higher
than that would be expected from 21 doublings of PCR (1.3 ± 0.1 x 10-5) based on the
results of the independent PCR experiments (Fig. 33). The differences in the mutant
fraction could be due to the different batches of Pfu polymerase used in the two sets of
experiments, implicating that polymerase microheterogeneity might play a role. However,
the possibility that other sources might also contribute to the observed background
mutations in the untreated cells can not be ruled out.
It is important to note that some of these background mutations could have arisen
from replication mismatch intermediates or DNA lesions either preexisting in the cells or
produced by the experimental procedures themselves. In our previous studies of
mitochondrial DNA mutational spectra, evidence was found to suggest that some of the
mutations might have arisen from cellular DNA adducts or replication mismatch
intermediates existing in the cells prior to DNA isolation (Khrapko et al., 1997a).
Resolution of this issue in the nuclear gene study must await application of the previously
described procedure in which mutant fractions are independently determined for the original
antiparallel DNA strands in the cellular DNA (Khrapko et al., 1997a).
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Figure 33. The mutant fraction of all low Tm mutants created by Pfu as a function of the
number of doublings. The mutant fractions after 15 and 30 doublings of three independent
experiments were estimated by comparing the total area under all low Tm mutant peaks
(migrating between 29 and 42 minutes in Fig. 32) with the area under the internal standard.
A linear regression analysis was applied to all data points. The slope of the line was
estimated to be 8.2 x 10-5 total low Tm mutations per doubling. The dash lines represent
the 95% confidence interval.
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4.7. Single nucleotide polymorphisms in the APC target sequence in human
populations
The CDCE/high-fidelity PCR approach developed for detecting somatic point
mutations in human genomic DNA can be readily employed in screening for single
nucleotide polymorphisms (SNPs) in human populations. As a preliminary study, SNPs
were searched for in the 121-bp APC gene target sequence in 2000 juveniles under the age
of six. Two sets of pooled blood samples were created, with 1000 donors in each set.
Genomic DNA was isolated from the pooled blood. About 1 pg of the genomic DNA,
which contained 3 x 105 copies of the APC gene alleles (or 3 x 102 alleles from each
person), was doped with an internal standard at a mutant fraction of 10-2 and amplified by
high-fidelity PCR. The amplified products were converted into homoduplexes and
separated on CDCE. Genomic DNA from TK6 cells was analyzed in parallel to serve as a
negative control.
Fig. 34 shows the CDCE separations of the homoduplexes derived from genomic
DNA of TK6 cells and the two sets of pooled blood samples, each in duplicate. Distinct
from the TK6 negative control, a predominant SNP peak was observed in the blood
samples. This peak has been isolated and identified to be a novel GC -> TA transversion at
the position of APC cDNA bp 8613. The allele frequency of this SNP was estimated to be
9.5 and 12.5%, respectively, in the two 1000-juvenile populations. This is the first
reported SNP in this particular APC gene sequence in human populations. Its biological
implication remains to be determined.
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Figure 34. CDCE separations of the homoduplexes derived from genomic DNA of TK6
cells and the two sets of pooled blood samples.
CDCE was performed at 9 gA and using a 19-cm water-jacket at 64.80'C. Indicated are
the wild-type DNA, the internal standard (std.) at 10-2, and the SNP with its frequencies
determined in the corresponding blood samples. "X" and "Y" mark unknown PCR
artifacts.
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4.8. Conclusions
Based on two crucial technical improvements, our previously developed
CDCE/high-fidelity PCR approach has been extended to mutational spectrometry of nuclear
genes, exemplified here by a 121-bp APC gene sequence (Fig. 25). First, sequence-
specific hybridization coupled with a biotin-streptavidin capture system was employed to
enrich the target sequence from genomic DNA by 10 4-fold. Using this strategy, several
milligrams of genomic DNA, which are required for reproducible observation of nuclear
gene mutations at fractions as low as 10-7 - 10-6, were reduced to less than I gg containing
the desired target sequence with a yield of greater than 70%. This large reduction in sample
size permitted the subsequent procedure for mutant enrichment. The second improvement
was a wide-bore capillary electrophoresis technique to enrich for mutant sequences in the
presence of the residual cellular DNA. CE using a 540 gm i.d. column provided a large
sample loading capacity, a high separation resolution and an excellent target sequence yield
(almost 100%). A 100 - 200-fold mutant enrichment was achieved through two
consecutive separations of CDCE and CE at room temperature. The high efficiency of
mutant enrichment in combination with subsequent high-fidelity PCR using Pfu DNA
polymerase created a means of sufficient sensitivity to measure nuclear point mutations at
fractions as low as 10-6.
The validity of the approach has been tested in the study of MNNG-induced point
mutations in the 121-bp APC target sequence in MT I cells. Distinct from the background
mutations in the untreated controls, twelve GC -> AT transitions were reproducibly
observed in the MNNG-treated cells at fractions ranging from 2.2 x 10-6 to 9.2 x 10-6
(Figs. 27 - 29). These transitions predominantly occurred at guanine residues preceded
(5') by a purine. The results with regard to the kind of mutation induced by MNNG and
its site specificity agree with previous observations in E. coli, yeast and other human
systems (Burns et al., 1987; Richardson et al., 1987; Kohalmi and Kunz, 1988; Yang et
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al., 1991; Kat, 1992).
In the untreated MT1 cells, fourteen background mutations were identified. All
fourteen mutations were GC -> TA transversions at mutant fraction around 10-6. The
observations of the same set of transversion mutations in TK6 cells indicate that they are
unlikely to exist as true mutants in the cells. Independent PCR experiments using CDCE-
purified wild-type DNA confirmed that Pfu-induced mutations were the major source for
these transversions. The results suggest that in order to further increase the current
detection sensitivity, one would need to improve the mutant enrichment efficiency prior to
PCR and/or decrease the level of PCR noise.
The approach described herein can be applied to all DNA sequences suitable for
CDCE analysis. It is independent of phenotypic selection and thus permits the direct
observation of mutagen-induced mutational spectra in a single cell system without being
potentially biased by any "protein filter" effect. Most importantly, it opens the opportunity
to study mutational spectra in human tissues and organs. The current detection sensitivity
should be sufficient for the observation of stem cell mutations in a tissue sector consisting
of 107 - 108 cells. Mutations in a stem cell may be found as a colony consisting of 100 -
200 cells after the mutations are transmitted to the transitional and terminal cells of that stem
cell's turnover unit. The mutant fraction of a stem cell mutation in a tissue sector would be
either zero or 10-6 - 10-5, which is above the detection limit of this approach. In addition to
detecting somatic mutations, the techniques developed here should also find facile
applications in simultaneous screening of large numbers of samples to establish the nature
and frequency of rare genetic polymorphisms in human populations.
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5. SUGGESTIONS FOR FUTURE RESEARCH
5.1. Studies of mutagen-induced mutational spectra in vitro
Analysis of the site-specificity of a mutational spectrum in a given target sequence
may reveal the sequence-specific mechanisms of the mutagenic processes by a given
mutagen including initial adduct formation, adduct removal and replication bypass.
However, it has been argued that such an analysis is often biased to some extent since the
mutation systems used are based on phenotypic selection which confines the analysis to
mutations that can produce a functionally altered protein (Gordon and Glickman, 1988;
Echols and Goodman, 1990). The CDCE/high-fidelity approach now provides a means to
directly address this issue. The mutagen-induced mutational spectra in a selectable gene
sequence (such as the hprt gene exon 3 low melting domain) can be analyzed and compared
under conditions with and without phenotypic selection .
5.2. Studies of mutational spectra in nuclear genes in human tissues
The application of the CDCE/high-fidelity PCR approach to human tissue analysis
may be first tested in chronically sun-exposed normal skin. Studies of the p53 gene in sun-
exposed, normal human skin have identified UV radiation as the causative agent which
produces predominantly C -> T and CC -> TT transitions at dipyrimidine sites (Nakazawa
et al., 1994; Jonason et al., 1996; Ren et al., 1997). In these studies, keratinocytes
containing mutated p53 protein were observed as immunopositive "patches". Each patch
was an independent mutant colony expanded from a mutated stem cell. The average
number of the p53 patches per cm 2 was found to be three in sun-shielded skin and thirty in
sun-exposed skin (Jonason et al., 1996). Although mutations in other nuclear genes may
not cause selective clonal expansion of epidermal cells, it is expected that due to the
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constant renewal of the epidermis, mutations in a stem cell will be at least descended to the
transitional and terminal cells of that stem cell's turnover unit. Thus, the mutant fraction in
the entire epidermis is at least equal to that in the stem cell population.
Based on studies of human epidermal cell proliferation kinetics and colony forming
efficiency (Potten, 1981; Weinstein et al., 1984; Potten and Morris, 1988; Jones and Watt,
1993; Heenen and Galand, 1997), it is estimated that under 1 cm 2 surface area of human
epidermis, there are a total of 4.4 x 106 keratinocytes, among which 7 x 104 cells are stem
cells. Since there are about thirty p53 patches in sun-exposed skin, the mutant fraction in
the stem cell population is 4.3 x 10-4 (= 30/70,000). Assuming the p53 target size is 1000
base pairs, the average mutant fraction is estimated to be 4.3 x 10-7 per bp in nuclear genes
in sun-exposed skin. Mutational hotspots with a 10 - 100-fold increase in the mutant
fraction would be at fractions of 4 x 10-6 - 4 x 10-5, which is above the current detection
limit of the CDCE/high-fidelity PCR approach. To reproducibly observe these hotspots, 1 -
10 cm 2 of epidermis (4 x 106 - 4 x 107 cells) would be required for the analysis.
The mutant fraction of nuclear genes in normal internal organs is expected to be
lower than that in sun-exposed skin. The mutant fraction at the hprt and HLA loci in
peripheral T-lymphocytes has been reported to be about 10-5 in humans 50 years of age
(Grist et al., 1992; Robinson et al., 1994). Assuming a target size of 1000 base pairs, the
average mutant fraction is estimated to be 10-8 per bp. Mutational hotspots with a 10 - 100-
fold increase in the mutant fraction would be at fractions of 10-7 - 10-6. To analyze
mutations in internal organs, anatomically distinct sectors may be dissected and analyzed in
series (Coller et al., 1998). Mutations in a stem cell may be found in as a colony the size of
a turnover unit. Assume that the size of a turnover unit may contain 128 cells (H. Zarbl,
personal communication), the mutant fraction of a hotspot in a tissue sector consisting of 5
x 107 cells would be either zero or greater than 10-6, which is above the current detection
limit. To establish a mutational spectrum in an internal organ such as colon, 108 - 109 cells
or 24 - 240 cm 2 of colon mucosa (Potten et al., 1992) would be required for the analysis.
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5.3. Studies of SNPs in human populationsli
The identification of SNPs has significant importance for mapping and discovering
disease-associated genes. Based on the hypothesis that the disease-causing SNPs present
in newborns should be significantly decreased in centenarians, it has been proposed that by
comparison of the SNP spectra in newborns and centenarians, one may identify SNPs
associated with mortal diseases as well as the genes in which they reside (Tomita-Mitchell
et al., 1998). Such studies require the examination of a large number of people in order to
identify numerically significant SNPs. A population of 10,000 people has been suggested
(Tomita-Mitchell et al., 1998). The analytical power of the CDCE/high-fidelity PCR
approach offers a cost-efficient means to simultaneously screen such a large population and
allow for detection of rare SNPs at frequencies as low as 5 x 10-4 in virtually any ~100-bp
DNA sequence.
The experimental plan would be as follows. A pooled DNA sample is created from
blood drawn from a cohort of 10,000 persons. To reduce the sampling variation, 100 -
1000 white blood cells (corresponding to about 0.1 - 1 p1 of blood) per person should be
used for each analysis (Tomita-Mitchell et al., 1998). The pooled DNA sample is expected
to contain 6 - 60 gg of genomic DNA extracted from a total of 106 - 107 white blood cells.
After restriction digestion, the sequence-specific enrichment technique is employed to
enrich the desired target sequences. An appropriate choice of endonucleases used in the
digestion should permit sequential enrichment of multiple target sequences from the same
pooled sample. The target-enriched sample is amplified by high-fidelity PCR and subjected
to a CDCE-PCR-CDCE procedure to enrich, amplify and finally display the SNPs.
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